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Abstract 
Ezrin, radixin, and moesin (ERM) family proteins regulate cytoskeletal responses bytethering the plasma 
membrane to the underlying actin cortex. Mutations in ERM proteins lead to severe combined 
immunodeficiency, but the function of these proteins in T cells remains poorly defined. Using mice in 
which T cells lack all ERM proteins, we demonstrate a selective role for these proteins in facilitating 
egress from lymphoid organs in response to sphingosine-1-phosphate (S1P), a pleiotropic signaling lipid 
abundant in the blood and lymph. ERM-deficient T cells display defective S1P-induced migration in vitro, 
despite normal responses to standard protein chemokines that control entry into and migration within 
lymphoid organs. Analysis of these defects revealed that S1P promotes a fundamentally different mode 
of migration than chemokines, characterized by intracellular pressurization and bleb-based motility. ERM 
proteins facilitate this process, controlling directional migration by limiting blebbing to the leading edge. 
We propose that the distinct modes of motility induced by S1P and chemokines are specialized to allow T 
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Ezrin, radixin, and moesin (ERM) family proteins regulate cytoskeletal responses by 
tethering the plasma membrane to the underlying actin cortex. Mutations in ERM 
proteins lead to severe combined immunodeficiency, but the function of these proteins in 
T cells remains poorly defined. Using mice in which T cells lack all ERM proteins, we 
demonstrate a selective role for these proteins in facilitating egress from lymphoid 
organs in response to sphingosine-1-phosphate (S1P), a pleiotropic signaling lipid 
abundant in the blood and lymph. ERM-deficient T cells display defective S1P-induced 
migration in vitro, despite normal responses to standard protein chemokines that control 
entry into and migration within lymphoid organs. Analysis of these defects revealed that 
S1P promotes a fundamentally different mode of migration than chemokines, 
characterized by intracellular pressurization and bleb-based motility. ERM proteins 
facilitate this process, controlling directional migration by limiting blebbing to the leading 
edge. We propose that the distinct modes of motility induced by S1P and chemokines 
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CHAPTER 1: INTRODUCTION 
1.1:  Cell Migration and Immunity  
 From bacteria to mammals, cellular motility is integral to life. Single-cell 
organisms rely on motility for the acquisition of nutrients and the evasion of harsh or 
toxic environments [1]. In multicellular organisms, motility plays a fundamental role in 
development, but most terminally differentiated cells are non-motile [2]. Some cells, like 
erythrocytes, move throughout the body passively via blood flow, but do not actively 
migrate on their own. In the mature host, cell motility is particularly important for the 
hematopoietic compartment, where it plays an indispensable role in immunity. Among 
his many observations, Élie Metchnikoff noted that leukocytes not only extravasate into 
inflamed tissues, but that this process continues even after the death of the host when 
blood flow has ceased – an early indication of leukocytes’ intrinsic migratory capacity [3]. 
 Leukocytes use their special migratory abilities to the survey the host for 
infections. Fundamental differences in how myeloid and lymphoid cells detect microbes 
has resulted in two complementary but distinct surveillance programs. Innate immune 
cells use germline-encoded receptors to detect common microbial products, allowing a 
small number of tissue-resident sentinel cells at barrier sites to recognize a wide variety 
of pathogenic threats and mobilize circulating myeloid cells to the site of infection en 
masse [4, 5]. Generic pathogen recognition is a luxury not afforded to lymphocytes. 
Genetic recombination events during lymphocyte development produce a pool of T and 
B cells with immense diversity in their antigen receptor specificity [6], but this creates a 
separate problem. In an adult mouse, this resulting repertoire contains only ~100 naïve T 
cells capable of responding to any given antigen [7, 8]. Since naïve lymphocytes have 
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no way of knowing where their specific or “cognate” antigen may appear, they must 
perpetually traffic throughout the host in a process termed homeostatic immune 
surveillance. This introductory chapter details this surveillance process first at the 
organismal level (trafficking) and then at the cellular and molecular levels (migration). 
1.2: Lymphocyte Surveillance  
Naïve T cell Trafficking  
 The main purpose of T cell homeostatic surveillance is the detection of rare, 
cognate antigens. Antigens and antigen-presenting cells (APCs) collect regionally in 
lymph nodes and other secondary lymphoid tissues distributed strategically throughout 
the host, allowing naïve lymphocytes to sample locally available antigens without 
surveying the entirety of the tissue [9]. For T cells, homeostatic immune surveillance 
occurs in four discrete steps: 
1. Circulating T cells enter into lymph nodes from the blood. 
2. T cells migrate intranodally, scanning APCs for cognate antigen in the form of 
peptide-MHC complexes.   
3. If no cognate antigen is detected, T cells egress from the lymph node via efferent 
lymphatic vessels.  
4. Lymphatics merge with the vasculature, returning to step 1.  
 
 If T cells spend too little time in a given lymph node, they are prone to missing 
rare cognate antigen. If T cells linger for too long, they may take unacceptably long to 
discover cognate antigen that has collected in a different node. In both cases, the result 
is the same: delayed onset of adaptive immunity. These two opposing evolutionary 
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forces have created an extremely efficient process guided by a variety of soluble and 
cell-bound migratory cues. Each step in this homeostatic immune pathway is outlined 
below.  
Lymph Node Entry  
 Initial entry into lymph nodes from the blood is a highly regulated process. 
Lymphocytes in the blood first interact with specialized high endothelial venules (HEVs; 
[10]) and gain access to the lymph node through the sequential function of three 
receptors: CD62L (L-selectin), C-C Chemokine Receptor Type 7 (CCR7), and 
lymphocyte function-associated antigen 1 (LFA-1). HEVs uniquely express a 
sulfotransferase that modifies cell surface proteins including CD34, GlyCAM-1, and 
MAdCAM-1 with a 6-sulfo sialyl LewisX carbohydrate group [11, 12]. These modified 
proteins are collectively referred to as peripheral node addressin (PNAd) and act as the 
ligand for CD62L [13]. The interaction between CD62L and PNAd captures circulating 
lymphocytes and causes them to begin rolling along the HEV surface [14]. T cell rolling 
along the endothelium permits CCR7 to bind to one of its ligands, CCL21, which is 
immobilized on the HEV luminal surface through an interaction with cell surface heparan 
sulfate [15]. CCR7-dependent signaling then drives LFA-1 from a bent, inactive 
conformation to an extended, highly active conformation. Extended LFA-1 binds to HEV-
expressed ICAM-1, and this interaction terminates rolling and promotes firm adhesion on 
the HEV walls [16]. Deletion or blockade of CD62L, CCR7, or LFA-1 prevents T cells 
from entering into lymph nodes, indicating that each homing receptor is necessary [17-
20]. Along those lines, neutrophils express CD62L and LFA-1 but not CCR7 and are 
therefore excluded from lymph nodes under normal conditions [21].  
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 In contrast to tethering, rolling, and firm adhesion, the actual process of 
transendothelial migration across the HEV or signals that prompt it are poorly 
understood. Autotaxin (ATX), an enzyme that converts the ubiquituous blood lipid 
lysophosphatidyl choline into lysophosphatidic acid (LPA), is highly expressed at HEVs. 
Pharmacological inhibition of ATX abrogates transendothelial passage and results in 
lymphocytes accumulating at HEVs, apparently unable to transverse [22]. Likewise, LPA 
promotes T cell polarization, motility, and transendothelial migration in vitro [23, 24]. 
However, T cells express multiple LPA receptors, and HEV cells themselves are 
responsive to LPA, which warrants further research into how LPA prompts 
transendothelial passage [24]. Along these lines, HEVs are not simple portals into the 
lymph nodes, but rather function as trafficking controllers by retaining T cells near the 
entry point to regulate T cell abundance in the lymph node parenchyma [25].  
Intranodal Migration  
 Within lymph nodes, various non-hematopoietic cell populations create a 
structural network that doubles as a migratory roadway for T, B, and Dendritic Cells [26]. 
T cells that enter lymph nodes through the HEVs are guided to the paracortex by a 
network of fibroblastic reticular cells (FRCs; [27, 28]). These cells highly express the 
chemokines CCL19 and CCL21, both ligands for CCR7, in addition to ligands for LFA-1 
and a second integrin, very late antigen 4 (VLA-4). T cells migrate directly on these FRC 
networks, which restricts migration to the paracortex, where T cells can scan APCs for 
cognate peptide-MHC complexes [29]. Deletion of CCR7 or its ligands results in T cell 
disorganization, migration defects, and associated immune deficiencies [18, 30]. 
Although CCR7 plays a major role in lymph node entry, these intranodal migratory 
defects are apparent even when HEV entry is bypassed by direct injection of T cells into 
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afferent lymphatics, indicating a clear role for CCR7 in intranodal guidance [31]. Further, 
CCR7-deficient T cells are severely disorganized in the spleen, which does not possess 
HEVs or utilize CCR7-dependent entry [18].  
 Follicular dendritic cells (FDCs) and marginal reticular cells (MRCs), two other 
non-hematopoietic stromal cell populations, form a corresponding network in the lymph 
node follicles. Unlike FRCs, FDCs and MRCs highly express the chemokine CXCL13, a 
ligand for the B cell chemokine receptor CXCR5 [32, 33]. CXCR5 thus guides recent B 
cell immigrants into the B cell follicle, but follows the same basic principles of migration 
guided by non-hematopoietic stromal cell networks as T cell migration to the paracortex 
[34]. Naïve T and B cell populations are therefore largely segregated from one another in 
secondary lymphoid organs. [34].  
Egress  
 T cells spend approximately 12 hours in a given lymph node searching for 
antigen and, if none is found, will leave via the efferent lymphatics [35]. T cells first 
egress by passing through lymphatic sinuses present in the lymph node cortex near the 
T cell zone. From there, lymphatic flow carries them to macrophage-rich medullary 
sinuses, then through the subcapsular space, and ultimately into the efferent lymphatic 
vessels [36]. The central signal guiding T cell egress is sphingosine-1-phosphate (S1P), 
a pleiotropic signaling lipid present in high concentrations in the blood and lymph, but 
maintained in low concentrations in the interstitial fluid of lymphoid organs [37]. This 
distribution creates a high-to-low S1P gradient between the circulatory fluids and 
lymphoid organs that T cells recognize with S1P receptor 1 (S1PR1, Edg1). Recognition 
of this S1P gradient with S1PR1 prompts T cell passage into the lymphatic sinuses from 
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the lymph node parenchyma [38, 39]. While lymph nodes typically exist in series, these 
lymphatics ultimately merge with the thoracic duct, which places lymphocytes back into 
blood, restarting the successive process of lymph node entry, intranodal migration, and 
egress.  
Variations in the Spleen 
 The spleen is the largest secondary lymphoid organ and maintains several 
distinctive features compared to lymph nodes that alter how T cells survey the organ. 
First, the majority of the splenic parenchyma, termed “red pulp”, is devoted blood 
filtration and other immunologically-independent functions [40]. Lymphocytes are 
concentrated in discrete regions termed “white pulp” [40]. Unlike lymph nodes, the 
spleen has no high endothelial venules. Instead, lymphocytes and antigen alike are 
transported into the spleen via the central arteriole, which carries them to the marginal 
zone – the demarcation between the red and white pulp [41]. Thus, relative to the lymph 
nodes, entry into the spleen is considered a passive process. Once in the splenic 
marginal zone, T and B cells segregate in the white pulp based on similar principles as 
the lymph nodes. T cells responding to CCL19 and CCL21 segregate from B cells 
responding to CXCL12 and CXCL13 [18, 42]. Marginal zone B cells, which are spleen-
resident and do not recirculate, are the primary APC population in the spleen [43-45]. 
The route of T cell egress from the spleen has remained ill-defined, but occurs directly 
into the vasculature in an S1PR1-dependent fashion [46]  
Effector Lymphocyte Trafficking  
 The majority of naïve T cells never find cognate antigen, but those that do enter a 
rapid proliferative phase that coincides with large-scale transcriptional changes [47, 48]. 
In addition to the acquisition of effector functions, activation results in profound 
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alterations in the expression of various chemoattractant receptors and adhesion 
proteins, which endows effector T cells with new surveillance and migratory capabilities. 
Shortly after T cell receptor (TCR) stimulation, T cells downregulate S1PR1, which 
causes them to remain lymph node resident during their highly proliferative phase [49]. 
Some effector T cells, especially CD8+ cells, will subsequently re-express S1PR1 to 
leave the lymph node and traffic to infected or inflamed peripheral tissues [50]. Entry into 
inflamed peripheral tissues by effector T cells is facilitated by the upregulation of VLA-4 
and expression of CD44, which bind to VCAM-1 and hyaluronic acid, respectively, both 
components of inflamed endothelia [51-53]. Activated T cells also shed CD62L, which 
prevents further entry into lymph nodes and thus facilitates peripheral homing [54-56]. 
 T follicular helper (Tfh) cells and germinal center B (GCB) cells remain in the 
draining lymph node following activation but alter their expression of chemoattractant 
receptors to coordinate germinal center responses. Naïve B cells normally localize to the 
follicle by virtue of CXCR5, with signaling through the receptor EBI2 biasing B cells to 
the outer perimeter [18, 34, 57]. Following activation, B cells downregulate CXCR5 and 
express the T cell chemokine receptor CCR7, which prompts their migration to the 
border of the T cell zone or paracortex [58]. At the T cell border, activated B cells interact 
with antigen-specific CD4+ T cells to form highly dynamic and mobile cell conjugates 
[59]. These B cells then migrate, guided by the receptor EBI2 and its oxysterol ligand, to 
the outer regions of the follicle near the subcapsular space (interfollicular zone) where 
they proliferate for 1-2 days prior to the formation of a proper germinal center [60-62]. 
Cognate T cells are also present at this interfollicular zone either through their own EBI2 
guidance [63] or by virtue of being dragged there by B cells [59]. Several days post-
activation, GCB cells and Tfh cells begin organizing formal germinal centers in the 
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center of the primary follicle. Movement from the interfollicular region to the nascent 
germinal center is mediated by the loss of EBI2 and expression of S1PR2 and P2RY8 by 
both Tfh and GCB cells. While S1P concentrations are substantially lower in lymphoid 
organs than blood or lymph, concentrations are not uniform across the tissue 
parenchyma. S1P concentrations are lowest in the center of the follicle, and the same is 
likely true for the ligand of P2RY8, S-Geranylgeranyl-L-glutathione  [64, 65]. S1PR2 and 
P2RY8 simultaneously inhibit lymphocyte migration to chemokines and appear to drive 
chemorepulsion away from gradients of S1P or S-Geranylgeranyl-L-glutathione, which 
culminates in Tfh and GCB cells tightly clustering in the center of the follicle [65-68]. 
Light and dark zones subsequently form, and GCB cells use CXCR4 to move into the 
dark zones and CXCR5 to move into the light zones [69]. 
Memory T cell Trafficking  
 Memory T cells that form after pathogen clearance can be divided into “central 
memory” and “effector memory” subsets based on their expression of trafficking proteins 
[70]. Central memory T cells retain expression of the critical homeostatic surveillance 
receptors CD62L and CCR7 and therefore continue a surveillance program of secondary 
lymphoid organs similar to naïve T cells [71]. Effector memory populations downregulate 
CCR7 and CD62L, which reduces their capacity to enter peripheral lymph nodes [70, 
72]. Effector memory cells primarily survey peripheral non-lymphoid tissue, but can enter 
lymph nodes through alternative receptors under some situations [73, 74]. Some 
memory T cell populations express tissue-specific homing receptors that allows them to 
preferentially survey tissues where a pathogenic threat was initially encountered. For 
example, expression of the chemokine receptors CCR4 and CCR10 promote preferential 
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trafficking to the skin  [75-77], and expression of the integrin α4β7 along with the 
chemokine receptor CCR9 promotes trafficking to the intestines [78-81].  
 Tissue-resident memory cells are a more recently-described subset that remain 
in peripheral tissues with no apparent re-circulation [82]. Tissue-resident memory cells 
have been observed in the skin [83, 84], intestines [85], lungs [86], salivary glands [87], 
and brain [88]. This tissue residency depends on the sustained suppression of S1PR1 
function, which otherwise prompts T cell movement into the circulatory fluids [89, 90]. 
Further, tissue-resident memory cells upregulate the integrin αEβ7, which is dispensable 
for entry into peripheral sites but is crucial for retention, likely by facilitating T cell 
interactions with tissue epithelial cells [88, 90-92]. 
 In summary, T cell trafficking is integral to adaptive immunity. Antigen search, 
effector function, and memory surveillance are all orchestrated by the local production of 
chemoattractants, chemoerepellents, adhesion ligands, and the cell-specific expression 
of their various receptors. Protein chemokines and lipid chemoattractants like S1P 
appear to play complementary but functionally distinct roles in this trafficking process. 
Much of the data presented in this dissertation is devoted to comparing how S1P and 
chemokines differentially influence T cell migration, and how that reflects their unique in 
vivo functions. We were able to address these questions by developing a cell culture 
technique that makes primary mouse T cells responsive to S1P through S1PR1 in vitro, 
and utilized this technique to compare and contrast S1PR1 and chemokine receptor 
signaling and migratory strategies. With the organismal-level picture of T cell trafficking 
now described, this introduction will now focus in on migration at the cellular and 
molecular levels.  
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1.3  Migration Strategies  
In its simplest form, cell migration occurs when a protrusion at one pole of the cell is 
coupled to subsequent retraction on the opposite pole. This process results in net 
displacement, especially when performed in cycles: protrusion, retraction, protrusion, 
retraction, and so on. While this is simple in principle, cells display an incredible amount 
of plasticity in how they move. This migratory diversity reflects both the heterogenous 
environments cells must migrate through and the biological purpose for their migration. 
For instance, straight line “ballistic” migration is ideal for a neutrophil chasing a 
pathogen, but impractical for a T cell searching numerous APCs for rare, cognate 
antigen. Additionally, cells may need to produce qualitatively different types of 
protrusions for crossing endothelial barriers compared to migrating within tissue 
parenchyma.  
Actin and Myosin  
 There are two central components that facilitate migration in cells: actin and 
myosin. Actin is a small globular protein that can be polymerized into filaments in a 
regulated fashion. In resting cells, actin filaments assemble subjacent to the plasma 
membrane to form the actin cortex [93]. These actin filaments are cross-linked by 
myosin, resulting in a higher order structure referred to as the actomyosin complex or 
simply actomyosin. Actomyosin controls fundamental biological properties like cell 
shape, membrane tension, and intracellular pressure and is central to all modes of 
migration [94-97].  
 Humans express up to 40 different myosin genes organized into more than 20 
distinct classes [98, 99]. All myosins possess an N-terminal catalytic motor domain that 
binds to actin [100, 101], but show great diversity in their C-terminal regions. This 
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diversity allows myosins to bind cargoes, assemble into filaments, and perform other 
functions. Myosin proteins operate by utilizing the energy gained from ATP hydrolysis to 
walk along actin filaments [102]. Depending on the myosin isoform and what the C-
terminus is interacting with, walking along actin filaments can transport cargo proteins or 
cause a cellular contraction [103].  
 The Myosin II subfamily is the largest group of myosins, and it encompasses the 
myosins that carry out the well-known contractile functions in cardiac, skeletal, and 
smooth muscle cells as well as three additional members termed non-muscle myosin IIs 
(NMIIs) that are expressed more broadly [99]. The C-terminus of myosin II heavy chain 
does not bind cargo but instead dimerizes with another myosin II protein in parallel 
fashion [104]. Each myosin II heavy chain in this dimer further associates with one 
essential light chain (ELC), which provides structural stability, and one regulatory myosin 
light chain (MLC), which modulates the activity of the catalytic motor domain [105, 106]. 
As a whole, this forms a hetero hexamer myosin complex, which further assembles into 
bipolar filaments [107]. When these myosin filaments collectively walk along actin, they 
cause the actin filaments to slide towards each other. This is an actomyosin contraction. 
When myosin is distributed unevenly over the cell cortex, actomyosin contractions can 
facilitate unique biological outcomes. Contractile activity at the cleavage furrow, for 
instance, mediate cytokinesis [108, 109]. In migratory cells, myosin classically localizes 
to the rear and powers trailing edge retractions [110-112]. 
 Non-muscle myosin II shows low levels of activity even in resting cells, which 
keeps the plasma membrane under slight tension and creates a heightened intracellular 
pressure [97, 113, 114]. This contractile activity is modulated by phosphorylation of the 
MLC, especially at the tandem Thr18 and Ser19 positions, which increases the ATPase 
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activity of the catalytic head domain [115-117]. These crucial sites are phosphorylated 
by Rho-associated protein kinase (ROCK), myosin light-chain kinase (MLCK), or other 
kinases to increase actomyosin contractile activity in response to various stimuli [118-
120].   
Protrusions – actin-polymerization vs blebs  
 Cellular protrusions are typically driven by actin polymerization against the 
plasma membrane. The initial polymerization of actin is energetically unfavorable and 
must be initiated by a class of proteins called nucleation promoting factors. Depending 
on the factors at play, actin can be polymerized into a dense, highly-branched 
meshwork, which generates sheet-like protrusions called lamellipodia or it can be 
polymerized into parallel linear bundles that generate finger-like projections called 
filipodia (Illustrated in Fig. 1.2A-B). Lamellipodia are generated by the Arp2/3 complex, 
which binds pre-existing filaments and nucleates a new filament at a 70-degree angle 
from the initial filament [121, 122]. Filipodia are generated by the formin family of 
proteins, which generate long actin cables by simultaneously promoting polymerization 
and blocking filament capping [123-125]. While some cells almost exclusively use 
lamellipodia or filipodia, cells frequently utilize a blend, with Arp2/3 contributing to 
filipodia formation [126] and formins contributing to lamellipodia formation [127]. 
Irrespective of the type of actin structure that cells use for their leading-edge protrusions, 
myosin plays a key role in trailing edge retraction [110-112].  
 Blebs are a fundamentally different type of protrusion than those generated by 
localized actin polymerization. Blebs occur when intracellular pressure causes the 
plasma membrane to herniate from the underlying actin cortex (Illustrated in Fig 1.2C). 
Blebs occur in three discrete phases: initiation, expansion, and retraction [128]. Under 
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normal conditions, the plasma membrane is tightly associated with the underlying actin 
cortex. Bleb initiation occurs when there is a decrease in the membrane-cortex 
association, an increase in intracellular pressure, or some combination of the two [129-
131]. Bleb expansion lasts only a few seconds, during which time the flow of cytosol 
causes inflation of the nascent bleb. The protrusion is devoid of actin or other major 
cytoskeletal machinery at this stage. Bleb formation is associated with an apparent 
increase in cell surface area [132], but lipid membranes can only stretch 2-3% before 
rupturing [133]. Bleb expansion thus appears to occur through the localized unfolding of 
small lipid invaginations to supply membrane during the expansion phase [134]. The 
actin cortex eventually reforms underneath the new protrusion, which ceases expansion 
[135, 136]. This reformation occurs sequentially, with ezrin, radixin, and moesin (ERM) 
family proteins first localizing the bleb membrane followed by actin, actin-bundling 
proteins, then myosin [137]. What promotes actin nucleation at the bleb membrane is 
unclear, as Arp2/3 and formins are conspicuously absent from nascent bleb at this time 
of cortex repolymerization [137]. Retraction is typically not observed in motile cells, with 
new blebs sprouting from old blebs as soon as the cortex has been repolymerized [135].  
 For blebs to drive productive migration, they must occur in a polarized manner. 
One initial study found that the driving force behind blebs – cytoplasmic pressure – could 
be unequally distributed throughout the cell, which could theoretically drive polarized 
blebbing [138]. Subsequent studies have challenged the notion of unequal cytoplasmic 
pressure, or at least its ability to drive polarized blebbing [139, 140]. Polarized blebbing 
could also occur under uniform intracellular pressure but localized weaknesses in the 
membrane-cortex interaction. Two studies in bleb-prone cancer cell models have shown 
that membrane-cortex linker proteins, especially ERM family proteins, accumulate at the 
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periphery and rear of migrating cells to limit blebbing outside the leading edge [141, 
142]. Defects in bleb-based migration have also been observed in ERM-deficient 
zebrafish progenitor cells [143]. Thus, ERM proteins serve dual roles in bleb prevention 
and retraction, with the former function playing a critical role in steering bleb-based 
motility.   
 While blebs have long been observed at the leading edge of migratory cells [144-
147], they have historically been less well-studied than actin-based protrusions [148], 
perhaps due to their association with apoptosis [149]. More recent studies showing that 
bleb-based migration occurs in vivo during development have quelled any notion that 
blebs are somehow artefactual or less physiologically relevant than their actin-based 
counterpart [135, 150]. Cells can alternate between actin-based protrusions or blebs 
depending on the extracellular environment, with cells preferring actin-rich pseudopods 
in two-dimensional settings and preferring blebs in confined settings [151, 152]. Further, 
lamellipodia seem optimized for migration on high-adhesion surfaces whereas bleb-
based motility largely relies on the traction afforded by confinement for net displacement. 
While most research on bleb-based motility has focused on non-hematopoietic cells, 
lymphocytes also display bleb-based motility in three-dimensional or confined settings 
[153]. A crucial open question is whether T cells toggle between actin polymerization 
and bleb-based motility for different migratory goals in vivo. Intravital imaging 
experiments have shown some indications of T cells using lamellipodia for intranodal 
migration and transendothelial migration through the HEVs [27, 154], but the transiency 
and protein-dim nature of blebs makes them difficult to study by these methods. Thus, a 
role for bleb-based migration in lymphocyte trafficking, if any, remains to be determined. 
In this thesis, I identify a role for bleb-based motility in response to S1P but not 
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chemokines, which will be covered extensively in the results and discussion portions of 
this document.  
 
1.4  Ezrin, Radixin, and Moesin Family Proteins  
Discovery and Evolution  
Ezrin, radixin, and moesin are the three members of the ERM protein family. Ezrin was 
first identified as a component of the brush border of chicken intestinal epithelial cells in 
1983 and named after Ezra Cornell, the founder of Cornell University [155]. This was 
followed up by the identification of moesin in bovine uterus smooth muscle cells [156] 
and radixin from rat hepatocytes [157, 158]. Moesin is an acronym for membrane-
organizing extension spike protein, and radixin, first identified as a component of 
adherens junctions was named after radix, the Latin word for “root” or “foundation”. 
Ezrin, radixin, and moesin are highly homologous at the amino acid level (~85% in mice 
and humans) and are generally considered to be functionally overlapping if not simply 
redundant when co-expressed in a cell [159-161]. Most cells express multiple ERM 
family members [162], and deletions of individual members typically only cause overt 
phenotypes in cells or tissues where that isoform is exclusively expressed. Radixin, for 
instance, is uniquely expressed in the cochlear stereocilia, and global deletion results in 
progressive auditory loss in mice with limited phenotypes observed in other tissues 
[163].   
 A single ERM ortholog most closely related to moesin is common in non-
vertebrates including fruit flies (Drosophila melanogaster; [164]), nematodes 
(Caenorhabditis elegans; [165, 166]), and tunicates (Ciona intestinalis; [167]). Ezrin and 
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radixin are suspected to have arisen from gene duplication events in a common ancestor 
to vertebrate animals [168, 169]. While most vertebrates encode ezrin, radixin, and 
moesin in their genomes, several animals, especially birds and fish, deviate from these 
norms. For instance, Atlantic Salmon (Salmo salar) harbor ten ERM genes (2 ezrin, 4 
radixin, and 4 moesin), and complete loss of the moesin gene is observed in many 
species of birds [169] .  
Structure, Function, and Regulation 
 The primary function of ERM family proteins is to link the plasma membrane to 
the underlying actin cortex in a regulatable manner. All ERM proteins have an 
approximately 300 amino acid N-terminal FERM (4.1 protein, ezrin, radixin, moesin) 
domain that binds to the membrane phosphatidyl inositol (PtdIns) lipid PtdIns(4,5)P2 
(PIP2) at the inner leaflet of the plasma membrane, an approximately 200 amino acid 
intermediary region, and an approximately 100 amino acid C-terminal region (C-
ERMAD) that contains an actin-binding domain (ABD; Fig. 1.3a; [170-172]). By 
simultaneously binding to the membrane and the actin cortex, ERM proteins are able to 
tether these two structures together (Fig. 1.3b).  
 ERM proteins are conformationally regulated, existing in either inactive or active 
forms. The inactive form occurs through a head-to-tail intramolecular interaction that 
masks both the membrane and actin binding sites (Fig. 1.3b [173, 174]). ERM proteins 
undergo a two-step transition into the active conformation. First, an initial interaction with 
PIP2 causes a slight conformational change that unmasks a critical threonine residue 
(Thr558 for moesin) in the ABD [175-177]. Second, phosphorylation of this threonine 
residue destabilizes the interaction between the FERM and ABD domains, driving a 
conformational change into the active, open state where the protein can simultaneously 
17 
 
bind the membrane and actin [178-180]. The PIP2 binding and threonine 
phosphorylation occur sequentially, with both being critical for ERM linker function [175, 
181]. Replacing this critical threonine residue with aspartate creates a phospho-mimetic 
mutant that is constitutively active. Overexpression of this mutant generates aberrant 
actin-dependent membrane structures like microvilli and often interferes with cellular 
functions [182-185]. In the open conformation, the FERM domain is also reported to bind 
to numerous protein binding partners at the plasma membrane to help organize and 
regulate signaling events [186]. 
 Various kinases are reported to phosphorylate the regulatory threonine residue in 
the ABD including PKCα [187], PKCθ [188], ROCK [178, 182, 189], NIK [190], LOK [191, 
192], and several others [193]. Many of these kinases act in a context-specific manner, 
enabling specialized functions of ERM proteins across different tissues. The most 
compelling evidence for the relevant ERM kinase in lymphocytes is for LOK 
(lymphocyte-oriented kinase, STK10). In the absence of LOK, cells from the spleen, 
lymph nodes, and bone marrow all display substantial reductions (~80%) in resting ERM 
phosphorylation levels along with altered migratory responses [191]. On the other end, 
both myosin phosphatase and protein phosphatase 1α (PP1α) have been reported to 
dephosphorylate ERM proteins at the regulatory threonine residue [194-197]. The 
dynamic regulation of ERM protein activity through dephosphorylation/rephosphorylation 
is critical to several biological processes. For example, during cell division, broad ERM 
phosphorylation first promotes cell rounding and spindle alignment and subsequent 
dephosphorylation selectively at the poles facilitates cytokinesis [198-202].   
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The Role of ERM Proteins in Epithelial Cells 
 ERM proteins are also regulated by subcellular localization. In a variety of tissue 
and cell types, phosphatidyl inositol kinases, phosphatases, and lipases coordinate to 
form asymmetrical distributions of PtdIns species variably phosphorylated on their 
inositol ring [203-207]. In tubular organs, PIP2 is concentrated in the apical membranes 
of epithelial cells and absent from basolateral regions, whereas PtdIns(3,4,5)P3 (PIP3) 
shows the opposite distribution [205, 206]. Through their interaction with PIP2, ERM 
proteins are commonly localized to the apical membranes where they play crucial roles 
in maintaining actin-dependent structures. Ezrin, for instance, localizes to apical domain 
of intestinal epithelial layers and controls villus morphogenesis. In the absence of ezrin, 
mice die perinatally due to defective nutrient absorption secondary to issues with their 
brush border organization [208]. The sole ERM protein in Drosophila plays a similar role 
in maintaining epithelial polarity during development [209].  
The Role of ERM proteins in Leukocytes  
 As in epithelial morphogenesis and maintenance, phosphatidylinositol species 
display a polarized distribution in migratory cells. From amoebas to leukocytes, PI3K and 
PTEN coordinate to concentrate PIP3 at the leading edge and PIP2 at the periphery and 
rear of polarized, migrating cells [203, 210-212]. Just like PIP2, ERM proteins localize to 
the periphery and rear of migratory amoebas [213], neutrophils [214], lymphocytes [215], 
and various cell lines [142]. However, the role of ERM proteins in cell migration has 
remained enigmatic.  
 Lymphocytes express high levels of moesin, moderate amount of ezrin, and 
negligible amounts of radixin [216, 217]. Chemokine stimulation in both T and B cells 
drives rapid ERM dephosphorylation lasting between 10-60 minutes [184, 217, 218]. The 
19 
 
fraction of ERM proteins that remain phosphorylated following chemokine stimulation 
localize to the uropod, a specialized membrane structure in the rear of polarized 
lymphocytes [215, 219]. The importance of the remaining pool of active ERM proteins, if 
any, is unclear as ERM-deficient T cells can chemotax normally in most scenarios [220].  
 Several groups have investigated a role for ERM proteins in lymphocyte 
polarization or the formation of uropod structures, often yielding conflicting results. 
Stephen Shaw’s group reported that expression of a phospho-mimetic moesin (T558D) 
potently interfered with chemokine-induced T cell polarization [184], whereas Martinelli 
et al. reported that expression of an analogous phospho-mimetic ezrin (T567D) led to 
excessive T cell polarization, even in the absence of chemokine [221]. This discrepancy 
doesn’t appear to be an ezrin vs moesin difference, as the Shaw group later reported 
that transgenic expression of phospho-mimetic ezrin (T567E) also blocked T cell 
polarization and potently interfered with migratory responses [185]. Martinelli et al. 
reported that a dominant negative version of ezrin blocked chemokine-induced 
polarization, but these data must be interpreted with caution since this construct has the 
potential to interfere with any PIP2-binding protein or PIP2-dependent process [221]. 
Using ezrin-knockout, moesin-knockdown (ERM-deficient) T cell blasts, Chen et al. 
found that ERM proteins were important for uropod formation in response to β1, but not 
β2 integrin engagement [220]. These data indicate that ERM proteins are not required 
for polarization per se, but may facilitate it under some conditions. Likewise, ERM-
deficient neutrophils stimulated with the chemokine CXCL1 show only mild polarization 
defects [222]. 
 Irrespective of these context-dependent alterations in uropod formation or 
polarization, ERM proteins are largely dispensable for actual migratory responses under 
20 
 
most circumstances. ERM-deficient T cells chemotax normally in transwell assays and 
migrate normally in collagen gel matrices [220]. When the pore size in the transwell is 
reduced from 5-microns to 3-microns, ERM-deficient T cells do show consistent 
migratory defects, likely indicating a preferential need for ERM proteins in confined 
settings [220]. 
 While much of the in vitro work on the migration of ERM-deficient T cells shows 
underwhelming phenotypes, there is compelling in vivo data from both mice and humans 
that these proteins play a critical role in lymphocyte trafficking. First, mice with a 
germline deletion in moesin were originally reported to be phenotypically normal [223], 
but closer analysis revealed these mice are lymphopenic due to a cell-intrinsic 
lymphocyte egress defect [224]. How moesin facilitates egress remains unclear. Second, 
hemizygous missense mutations in moesin cause severe combined immunodeficiency 
(SCID) in humans, with patient T cells showing potent migratory defects in vitro [225]. 
This disease, termed X-linked moesin-associated immunodeficiency (X-MAID), is 
characterized clinically by profound lymphopenia, moderate neutropenia, poor vaccine 
responses, and recurrent bacterial and viral infections [225]. Six out of the seven 
patients described in this initial cohort have the same hemizygous missense R171W 
mutation in the moesin FERM domain, but the effect of this mutation on moesin function 
is still unknown. Since 2016, four additional SCID patients with this same R171W 
mutation have been identified by newborn screens or whole exome sequencing [226-
228]. 
 In addition to their role in lymphocyte trafficking, ERM proteins also appear to 
carry out additional, often disparate, functions in lymphocytes. Although B cells express 
high levels of moesin, loss of ezrin alone results in augmented B cell receptor (BCR) 
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signaling and dysregulated humoral immune responses. Ezrin-deficient B cells display 
enlarged BCR microclusters at the membrane following stimulation and exhibit a 
corresponding increase in downstream signaling [229]. This effect is not recapitulated in 
ezrin-deficient T cells, which show modest diminution of TCR signaling and associated 
defects in cytokine production and activation [217]. In T cells, ezrin and moesin localize 
to the posterior region during immunological synapse formation, forming a membrane 
domain termed the distal pole complex. In this way, they are proposed to promote T cell 
activation by sequestering several negative regulators of TCR signaling [217, 230]. 
Finally, moesin has been implicated in maintaining CD8+ regulatory T cells by regulating 
IL-15-mediated signaling, and moesin-deficient T cells develop lupus erythematosus-like 
autoimmune phenotype with age [231]. 
 
1.5 Sphingosine-1-Phosphate (S1P) and S1P Receptors  
Regulation of S1P concentrations  
 Sphingosine-1-Phosphate (S1P) is a pleiotropic signaling lipid, and its 
concentrations in various tissues are tightly regulated. S1P is produced during normal 
sphingolipid metabolism and is therefore found in low concentrations in virtually all cells 
[232-234]. The transportation of intracellularly-generated S1P into the extracellular 
space, however, is highly specialized. S1P is most abundant in the circulatory fluids, and 
different cellular sources contribute S1P to the blood and lymph. In blood, extracellular 
S1P is produced by the hematopoietic compartment, with erythrocytes being the primary 
contributor [235]. Platelets also store large amounts of S1P that is released upon 
stimulation [236, 237], but platelet-derived S1P doesn’t appear to contribute to the 
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homeostatic serum or lymph S1P levels critical for egress [235, 238]. Both erythrocytes 
and platelets utilize the transporter Mfsd2b for S1P secretion. Deletion of Mfsd2b 
reduces serum S1P concentrations by approximately 50%, resulting in mild lymphopenia 
[239]. Additional S1P transporters in erythrocytes are suspected but not yet identified.   
 Lymphatic endothelial cells (LECs) are the major supplier of extracellular S1P to 
the lymph and are thus critical for egress from the lymph nodes [240]. LECs utilize the 
S1P transporter Spns2, and its deletion ablates virtually all lymph S1P [241]. The 
contribution of Spns2 to blood S1P is contested, with different groups reporting mild to 
severe reductions in serum S1P concentrations in the absence of the transporter [241-
243]. 
 Many biological functions depend not just on the presence of S1P but on the 
high-to-low concentration gradient that exists between the circulatory fluids and tissues, 
including lymphoid organs. S1P is irreversibly degraded into phosphoethanolamine and 
hexadecenal by S1P lyase, an intracellular enzyme located in the endoplasmic reticulum 
and mitochondria of various cells [244]. Pharmacologically inhibiting or genetically 
reducing S1P lyase activity creates a uniformly high S1P environment between lymphoid 
organs and circulatory fluids, and potently interferes with lymphocyte egress [37, 245]. 
S1P lyase is abundantly expressed by non-hematopoietic cells, but deletion in these cell 
lineages has no apparent impact on S1P concentrations in the interstitial fluid of 
lymphoid organs. Instead, the egress-relevant S1P lyase activity is restricted largely to 
CD11c+ dendritic cells that are positioned near egress sites [246].   
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S1P receptors in lymphocytes  
 Both mice and humans express five dedicated G protein-coupled receptors 
(GPCRs) for S1P (S1PR1-5). Naïve T cells express high levels of S1PR1 (Edg1), and 
deletion of this receptor severely reduces egress from primary and secondary lymphoid 
organs in a T cell-intrinsic manner [38, 39]. Within the lymph node, CCR7 and S1PR1 
act as competing retention and egress signals, respectively [247]. T cells limit the 
influence of S1PR1 in this balancing act through ligand-induced endocytosis. Cells in the 
S1P-rich circulatory fluids endocytose S1PR1, diminishing their attraction to blood or 
lymph and permitting their subsequent entry lymphoid organs [248]. Within the S1P-poor 
environment of the lymph node, T cells progressively upregulate surface S1PR1, 
restoring their sensitivity to S1P egress signals. In addition to controlling responsiveness 
to S1P, ligand-induced endocytosis also plays an important role in proper signaling 
through S1PR1 [249]. While ligand-induced endocytosis is crucial for homeostatic 
trafficking of naïve T cells, the lymph node retention of recently activated T cells is 
controlled by other mechanisms. Following T cell receptor recognition of cognate 
peptide-MHC or interferon signaling, T cells upregulate CD69, which interacts with 
S1PR1 on the plasma membrane and prompts its internalization [49]. Activation-induced 
S1PR1 downregulation is transient, and effector T cells eventually utilize S1PR1 to leave 
the lymph node, enter the blood, and access infected or inflamed peripheral tissues [50]. 
Memory T cells display different trafficking patterns than their naïve counterparts 
including the ability to survey non-lymphoid tissues [250, 251].  Tissue-resident memory 
T cells embed themselves in peripheral tissues and stop recirculating, a process that 
depends on the loss of S1PR1 expression [89].   
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 While most research on S1PR1 in lymphocytes has focused on its role in 
trafficking, the importance of S1PR1 is not limited to egress. The periodic burst of 
S1PR1 signaling that occurs during egress is also critical for maintenance of 
mitochondrial content and long-term survival of naïve lymphocytes [252]. S1P signaling 
through S1PR1 limits proliferation of common lymphoid progenitor cells to regulate 
lymphopoiesis [253]. Two- to three-fold overexpression of S1PR1 in T cells in vivo 
simultaneously inhibits the formation of regulatory T cells while promoting Th1 
differentiation [254]. Given that S1PR1 signaling appears to modulate T cell 
differentiation, it is worth exploring whether S1P concentrations change in draining 
lymph nodes or circulatory fluids during different kinds of pathogenic challenges.  
 In addition to S1PR1, naïve T cells express high levels of S1PR4, but the impact 
of S1PR4 on naïve CD4+ T cell trafficking is still subject to debate [255]. The weak 
phenotypes observed following loss of S1PR4 are somewhat surprising because unlike 
all other S1P receptors, S1PR4 is exclusively expressed in the hematopoietic 
compartment under normal conditions. One recent study found that S1PR4 does appear 
to synergize with S1PR1 for effector and memory T cells in peripheral tissues to gain 
access to draining lymphatics [256], but the role for S1PR4 in naïve T cell homeostatic 
surveillance is still unclear.  
 Various S1P receptors play critical roles in the function of other lymphocyte 
populations. S1PR5 is highly expressed by mature natural killer cells and controls their 
egress from the bone marrow into the blood [257, 258], playing a similar role as S1PR1 
does for T cells. S1PR3 is highly expressed by marginal zone B cells and functions 
alongside S1PR1 and CXCR5 to control Marginal Zone (MZ) B cell shuttling between the 
follicle and marginal zone in the spleen [45, 259].  
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 S1PR2 is distinct from the other S1P receptors. Poorly expressed in naïve 
lymphocytes, S1PR2 is strongly upregulated in GCB cells and Tfh cells [64, 67]. In both 
cell populations, S1PR2 promotes clustering in the germinal center where Tfh and GCB 
cells coordinate to produce high-affinity antibodies. In addition to controlling localization, 
S1PR2 limits the proliferation and signaling of GC B cells, and extreme outgrowths of 
these cell populations in chronically-established germinal centers occur in about half of 
S1PR2-deficient mice [64]. Whereas S1PR1, 3, 4, and 5 all promote chemotaxis in 
various lymphocyte populations in transwell assays, S1PR2 does not [39, 45, 256, 257]. 
On the contrary, when S1P is sensed through S1PR2 it can impede migration to 
chemokines or induce chemorepulsion on its own [64, 260]. Thus, while S1PR1, 3, 4, 5 
drive either egress or migration in response to S1P, S1PR2 appears to limit motility to 
control organization and positioning within lymphoid organs [261].  
S1PR1 function in non-lymphocytes  
 S1PR1 plays critical roles in non-lymphocytes, especially during development. 
Global deletion or knockdown of S1PR1 results in severe developmental defects in both 
mice and zebrafish due to impaired vascular development and associated edema [262-
264]. During vascularization, S1PR1 acts in a cell-intrinsic manner to promote mature 
blood vessel formation by antagonizing VEGF-driven angiogenic sprouting [265]. S1PR1 
is also crucial to platelet production, and conditional deletion of S1PR1 in 
megakaryocytes results in severe thrombocytopenia. In these cells, S1PR1 responding 
to S1P gradients guides megakaryocyte proplatelet extensions into bone marrow 
sinusoids to permit platelet release [266]. How a single ligand-receptor pair drives such 
disparate biological outcomes in different cell types remains a fascinating question. 
Interestingly, ligand-induced S1PR1 endocytosis occurs quickly in lymphocytes but 
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slowly in endothelia following S1P exposure [267]. S1PR1 has been shown to exhibit 
sustained signaling from endosomes in some contexts [268], which creates the 
possibility that cells may derive different outcomes from S1PR1 ligation by shunting the 
receptor to different subcellular localizations where it may engage in different signaling 
pathways. While this has not demonstrated for S1PR1, internalization-dependent 
signaling events have been demonstrated for other GPCRs [269].     
S1PR1 structure and ligand binding  
 Due to its lipid nature, S1P also binds to its receptors in an atypical fashion. Like 
all GPCRs, S1PR1 possesses a seven-pass transmembrane region, but the extracellular 
region normally involved in ligand binding is occluded by an N-terminal helical region in 
the crystal structure [270]. There is an abnormally large gap between helices I and VII in 
the transmembrane region, however, and S1P is thought to access the binding pocket 
by first integrating into the outer leaflet of the plasma membrane and then diffusing 
laterally into this pocket [270-272]. This method of ligation explains why S1P shows such 
slow saturation of S1PR1 binding sites and how S1P within the endosomal membrane 
can activate S1P receptors [273, 274]. 
 One additional layer of complexity for S1P is the very nature of peptide/protein vs 
lipid chemoattractants. While chemokines like CCL19 are readily soluble in aqueous 
solutions of the body, lipids like S1P are not. S1P is transported by binding non-
covalently to carrier proteins, with the primary partners being Apolipoprotein M (ApoM), 
the major protein component of high-density lipoproteins (HDL), and albumin [275, 276]. 
The degree to which the carrier protein impacts the outcome of S1P-S1PR1 interactions 
remains an open question. S1P-ApoM and S1P-albumin both stimulate the MAP kinase 
cascade through S1PR1 to similar degrees in endothelial cells, but the intracellular tail of 
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S1PR1 appears to bind differently to scaffolding proteins and promote different cellular 
responses depending on the carrier [277, 278]. Surprisingly, S1P bound to ApoM 
appears to be completely dispensable for T cell trafficking [253]. Even in mice doubly 
deficient in ApoM and albumin, lymphopenia isn’t observed, although other proteins are 
reported fulfill the S1P-carrying function in these animals [279]. It seems likely that 
S1PR1-dependent T cell egress is largely indifferent to the S1P carrier protein so long 
as sufficiently high S1P levels are maintained in the circulatory fluids. More work is 
needed to verify that this is the case. Most of the in vitro data on T cell responses to 
S1P, including the experiments detailed in chapters 2-3, utilize S1P conjugated to 
albumin.  
 
1.6 Structure of Thesis and Contributions 
 Following this introductory Chapter 1, this dissertation contains two chapters 
(Chapters 2 & 3) devoted to data. Chapter 2 details our characterization of a novel 
mouse model in which T cells are devoid of all ERM proteins, and concludes with the 
major finding that ERM proteins are particularly critical for S1P-dependent egress in vivo 
and S1P-induced migration in vitro. Chapter 3 then describes an atypical pressure-
driven bleb-based mode of migration elicited by S1P, and how this contrasts with 
standard actin-based motility elicited by chemokines. Chapter 3 concludes by showing 
that ERM proteins are selectively critical for S1P-induced bleb-based migration because 
they limit blebbing to the leading edge. In Chapter 4, I discuss the results from Chapters 
2-3 with a particular focus on how S1P could elicit such a profoundly different mode of 
migration than chemokines, and why bleb-based motility may be particularly useful for 
crossing specialized endothelial barrier during egress events.  
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Figure 1.1. Diagram of T cell Homeostatic Immune Surveillance 
T cell surveillance can be illustrated as a simple circuit. Moving clockwise, T cells first 
egress from the thymus directly into the vasculature. From the blood, T cells enter into 
lymph nodes through the high endothelial venules. Within the lymph node, T cells 
search for cognate antigen, and, if unsuccessful, egress via the efferent lymphatics. 
For lymph nodes that exist in series, these lymphatics carry the T cells directly into a 
downstream lymph node, where the T cells continues to search for antigen and, if 
unsuccessful, egress via the efferent lymphatics. The efferent lymphatics eventually 
merge with the vascualture at the thoracic duct, which puts the T cell back into 
circulation, permitting subsequent lymph node entry through the high endothelial 
venules. T cells can also access the spleen through the blood. In this case, T cells enter 
via the central arteriole, which places them at the marginal zone. These cells migrate 











Figure 1.2 Illustration of lamellipodia, filipodia, and blebs at the leading edge  
Illustrations showing leading edge morphology in cells migrating with lamellipodia (a), 
filipodia (b), or blebs (c). (a) In lamellipodia, actin organizes into a thin, flat meshwork. 
(b) In filipodial migraton, actin organizes into long protrusive bundles. (c) In bleb-based 
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Figure 1.3. ERM Protein Structure, Function, and Conformational Regulation
(a) The domain organization ERM proteins. All ERM proteins have an N-terminal FERM 
domain followed by an intermediary alpha-helical domain, a short linker region, and a 
C-terminal region (C-ERMAD) that  contains an actin-binding domain. The indicated 
amino acid positions are for specific to ezrin, but radizin and moesin contain analogous 
sites. The critical threonine residue, T5667, is shown. (b) In the open conformation (left) 
ERM proteins simultaneously bind to PI(3,4)P2 in the inner leaflet of the plasma 
membrane through their FERM domain and to the actin cortex through their C-ERMAD 
region. In the inactive, closed conformation, the protein assumes a head-to-tail 




CHAPTER 2: ERM DEFICIENCY RESULTS IN A T CELL-
INTRINSIC EGRESS DEFECT FROM LYMPHOID ORGANS 
 
2.1  Results  
ERM-deficient lymphocytes show an altered distribution among lymphoid organs 
and blood  
Co-expressed ERM proteins functionally overlap, and T cells express high levels 
of both moesin and ezrin. We generated germline moesin knockout mice (MKO) by 
targeted disruption of the Msn gene (Fig 2.1) and crossed them to mice with a 
conditional deletion of Ezn in the T cell compartment (ezrinFlox/Flox:CD4Cre, EKO; [217]) to 
generate animals in which mature T cells lack both gene products (double knockout, 
DKO). These mice were born at expected Mendelian frequencies and were visibly 
indistinguishable from wildtype littermates. Additionally, histological analysis did not 
reveal any overt pathology or aberrant accumulation of leukocytes in non-lymphoid 
organs (skin, liver, kidney, collected at 8-16 weeks of age, data not shown). Western blot 
analysis of CD4+ T cells confirmed that ezrin and moesin were deleted as expected from 
the single and double knockouts; radixin levels remained low (Fig. 2.2). Note that B cells 
in both MKO and DKO mice lack moesin, but continue to express ezrin. 
Analysis of secondary lymphoid organs from both MKO and DKO mice revealed 
marked alterations in lymphocyte distribution. Spleens were larger in size compared to 
WT mice and showed elevated cellularity and lymphocyte numbers, while inguinal and 
mesenteric lymph nodes showed diminished total cellularity and T cell numbers (Fig. 
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2.3a-e). Numbers of lymph node B cells were also reduced, although this did not reach 
statistical significance (Fig. 2.3d-e). Despite these alterations, ERM-deficient 
lymphocytes generally segregated into the correct anatomical locations within the 
spleens and lymph nodes, although the organization of these zones was more diffuse 
than in WT mice (Fig. 2.4a-g). Most striking, MKO and DKO mice displayed sharp 
reductions in the numbers of all lymphocytes in the blood (Fig. 2.3f). Overall, the 
phenotype of MKO and DKO mice was similar, but DKO mice consistently exhibited 
more pronounced phenotypes. This likely reflects the fact that moesin is the more 
abundant isoform in T cells, and the existence of functional overlap between ezrin and 
moesin in this setting. Given the more profound defects in DKO mice, only these animals 
were used for further experiments.  
Within the thymus of DKO mice, double negative and double positive thymocytes 
appeared in normal numbers and frequency, indicating no gross perturbations in T cell 
development (Fig. 2.5a-b). CD4 and CD8 single positive populations showed a mild 
increase; further analysis demonstrated that this was due to a significant accumulation of 
mature (CD24low, S1PR1hi) single positive thymocytes (Fig. 2.5c-f). This phenotype as 
well as the peripheral lymphopenia in DKO mice (Fig. 1f) are common features of mouse 
models with egress defects from lymphoid organs [38, 39]. Taken together, these data 
suggest that ERM proteins are important for homeostatic lymphocyte trafficking.    
ERM deficiency results in cell-intrinsic defects in egress from lymphoid organs 
 To ask whether the altered distribution of ERM-deficient lymphocytes reflects a 
cell-intrinsic trafficking defect, we performed competitive in vivo migration assays by 
labelling congenic WT and DKO naïve CD4+ T cells with cell tracking dyes and co-
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injecting them into the lateral tail veins of WT recipients (Fig. 2.6a). To distinguish 
between entry and egress defects, cells were analyzed 1-hour after injection, when 
egress is minimal, and 24-hours after injection, when trafficking is reaching equilibrium 
[35, 280]. 1-hour post-injection, DKO T cells showed a 30-40% reduction in lymph node 
entry and a corresponding elevation in the blood (Fig. 2.6b). This points to a role for 
ERM proteins in promoting T cell passage into lymph nodes across high endothelial 
venules. Entry into the spleen, which occurs via an open system continuous with blood 
[281, 282], was equally efficient for WT and DKO T cells. By 24 hours, DKO T cells 
accumulated in the spleen and showed a corresponding decrease in the blood (Fig. 
2.6c), indicating that DKO T cells fail to egress properly from the spleen. The relative 
paucity of DKO T cells in lymph nodes was maintained from 1 to 24 hours post injection, 
most likely because the reduced entry rate evident at 1-hr is matched by a reduced 
lymph node egress rate [35]. Importantly, the distribution of transferred T cells at 24 
hours matched the altered tissue distribution observed in the DKO mice (Fig. 2.2), 
indicating that the observed alterations in the DKO mice are T cell intrinsic. Taken 
together, these studies show that although loss of ERM proteins impairs both entry and 
egress from lymphoid organs, the egress defects drive the most profound phenotypes, 
including accumulation of mature thymocytes, splenomegaly, and severe peripheral 
lymphopenia. Thus, we focused on understanding the molecular basis for this egress 
defect.  
ERM proteins are selectively required for S1P-induced migratory responses 
The central signal that governs lymphocyte egress from lymphoid organs is 
sphingosine-1-phosphate (S1P), a pleiotropic signaling lipid that is rich in blood and 
lymph but low in interstitial fluids of lymphoid organs [37]. T cells recognize S1P through 
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the receptor S1PR1 (Edg1), which prompts egress [38, 39]. Our initial attempts to study 
S1P-induced migration in WT and DKO T cells were stymied by the fact that T cells are 
notoriously unresponsive to S1P in vitro [248, 249], a problem that is further complicated 
by the presence of S1P in cell culture serum. In other cell types, optimal S1P responses 
can be achieved by overnight culture in serum-free media [283], but this strategy results 
in unacceptable levels of death for primary T cells (data not shown). To maintain T cell 
viability, we utilized charcoal-stripped FBS (CS-FBS), which is devoid of lipophilic 
components. T cells cultured overnight in media supplemented with CS-FBS were 
mostly viable and displayed dramatically enhanced transmigration to S1P relative to 
freshly-isolated cells cultured for one hour in the same media (Fig 2.7a). Inhibiting 
S1PR1 with the selective antagonist Ex26 [284] completely abrogated transmigration, 
verifying that the response was S1PR1-dependent (Fig 2.7a).  
We initially hypothesized that T cells were sensing S1P during the isolation 
process and subsequently endocytosing S1PR1, which diminished responsiveness in 
our in vitro assays. However, freshly-isolated cells had only a slight reduction in surface 
S1PR1 relative to those cultured overnight, which seemed insufficient to explain the 
transmigration defect (Fig 2.7b). Although they started off with elevated F-actin content, 
freshly isolated cells polymerized actin in response to S1P comparably to those cultured 
overnight, with both groups returning to their own pre-stimulation set point (Fig.  2.7c). 
Despite this grossly normal actin response, downstream signaling through the ERK1/2 or 
AKT pathways in freshly isolated cells was severely reduced following S1P stimulation 
relative to those cultured overnight (Fig. 2.7d). Notably, this defective signaling in 
freshly-isolated cells did not extend to other chemoattractants like CCL19 (Fig. 2.7e). 
Both the actin and signaling responses to S1P were blocked by Ex26, indicating S1PR1 
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was driving both (data not shown). It remains unresolved why some aspects of S1PR1 
function (actin responses) are intact in freshly isolated cells and others (signaling) are 
defective. These data indicate that the actin responses can be at least partially 
uncoupled from downstream signaling events and may indicate unique aspects of 
S1PR1 regulation. Despite the unresolved aspects of the overnight culture procedure, it 
provided a method for more rigorously testing T cell responses to S1P in vitro than 
previously possible.  
Using this improved in vitro approach, we found that DKO T cells were highly 
defective in transmigrating towards S1P across multiple doses (Fig. 2.8a). Remarkably, 
transmigration towards CCL19 or CXCL12, two chemokines involved in naïve T cell 
trafficking [18, 285] was entirely normal (Fig. 2.8b-c). These data indicate that, while 
ERM proteins are not required for directed T cell migration generally, they are selectively 
critical for S1P-induced migratory responses. To understand why ERM proteins appear 
selectively critical for mediating S1P responses, I examined the modes of motility elicited 
by S1P versus chemokines in T cells. These experiments revealed fundamental 
differences between the responses to these various chemoattractants that explain the 
unique requirement for ERM proteins in S1P responses. These experiments are detailed 











Figure 2.1 Schematic of Msn targeting strategy 
The diagram shows the insertion of the trapping cassette into the first intron of 
the Msn gene in 129/Sv ES clones (OST4322827), which were used to 
generate the moesin knockout (MKO) mice used in this report.
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Figure 2.2 Verification of the deletion of ezrin and moesin 
CD4+ T cells harvested from the spleens and lymph nodes of mice with a T cell 
conditional deletion in ezrin (EKO), a germline deletion in moesin (MKO), or both (DKO) 
were lysed and immunoblotted with a pan-ERM antibody and for GAPDH. The ezrin 
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Figure 2.3. ERM-deficient lymphocytes assume an altered tissue distribu-
tion with 
severe lymphopenia. 
(a) Total cell counts from spleens (post-RBC lysis), inguinal and mesenteric 
lymph nodes from 8-16-week-old mice. (b) Spleens from age matched mice of 
the indicated genotype were weighed. (c-f) Cell suspensions and PBMCs were 
labeled for the indicated  surface markers, counted, and cell populations were 
quantified using flow cytometry. Data in a-f represent means +/- StDev. Each dot 
corresponds to an individual mouse. Statistical significance was determined 














































Figure 2.4 Organization of secondary lymphoid organs in DKO mice.
Immunofluorescence histology of spleens and lymph nodes from WT and DKO mice 
stained with antibodies against CD3 (white), B220 (blue) and laminin (red). (a-b) 
Confocal tile scans of whole spleens from WT and DKO mice, bar = 500 μm. (c-e) 
Magnified regions of spleens with the central arterioles (arrows) and marginal zones 
(MZ) labelled. Normal lymphocyte organization in WT and DKO spleens shown (c-d) as 
well as a representative region of poor organization in DKO spleen (e), bar = 100 μm. 


















































































































Figure 2.5 ERM-deficiency results in the accumulation of mature, single 
positive thymocytes 
(a-b) Representative flow plots and total numbers of the major thymocyte popu-
lations based on CD4 and CD8 expression. (c-d) CD4 single positive popula-
tions further analyzed by CD24 and S1PR1 expression to determine the num-
bers of semi-mature (CD24Hi S1PR1Low) and mature (CD24Low S1PR1Hi) subpop-
ulations in WT and DKO thymi. (e-f) CD8 single positive populations analyzed as 
in (c-d). Statistical significance for b, d, f determined by comparing the WT and 
DKO means using multiple t-tests and the Holm-Sidak method for correcting for 
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Figure 2.6 ERM-deficient T cells have a cell-intrinsic egress defect 
(a) Competitive in vivo migration experimental design. CD45 congenic WT and DKO 
naïve CD4+ T cells labelled with CellTracker Green (CMFDA) were co-injected 1:1 into 
the tail vein of WT recipient mice and harvested from the blood or indicated organ 1 hour 
or 24 hours later. (b-c) The ratio of the number of transferred WT and DKO T cells isolat-
ed from blood, spleen, or lymph node at 1 hour (b) or 24 hours (c) post-transfer. Each 








































































Figure 2.7 Overnight culture improves S1PR1 responses in T cells 
Following isolation, naive CD4+ T cells were cultured either overnight (O.N) or for 1 hour 
(1 Hr) in media supplemented with 10% charcoal-stripped FBS. (a) Percent transmigra-
tion of O.N. or 1 Hr cells towards the indicated concentration of S1P in the bottom cham-
ber of a transwell chamber. Cells in the Ex26 group were pretreated with 100 nM of the 
antagonist 20 minutes prior to the assay. Data pooled from 4 indpendent experiments. 
(b) Surface S1PR1 levels of O.N. and 1 Hr cells were determined by flow cytometry. 
Background (Bkgd) refers to cells stained without primary anti-S1PR1 antibody. Repre-
sentative plot from 2 independent experiments. (c) O.N. and 1 Hr cells were stimulated 
with S1P for the indicated amounts of time, fixed with PFA, stained with fluorescent-
ly-conjguated phalloidin, and analyzed by flow cytometry. Data is normalized to untreat-
ed O.N. cells and pooled data from 3 independent experiments. (d) O.N. and 1 Hr cells 
were stimulated with S1P (1 nM), lysed after 0, 0.5, 2, or 5 minutes, and immunoblotted 
for phospho-Erk (Thr2020/Tyr204), phospho-Akt (Ser473), and GAPDH. Only 
performed once. (e) O.N. and 1 Hr cells were stimulated with S1P (1 nM) or CCL19 (100 
ng/mL), lysed, and immunoblotted for phospho-Erk (Thr2020/Tyr204), phospho-Akt 

























































Figure 2.8 DKO T cells have a selective transmigration defect towards S1P. 
(a-c) Percent transmigration of WT and DKO naïve CD4+ T cells cultured overnight to 
the indicated concentration of S1P (a), CCL19 (b), or CXCL12 (c) in the bottom chamber 
of a transwell chamber. Each data point represents one technical replicate from one 
experiment, representative of 3-5 independent experiments. WT and DKO 
transmigration means for each concentration of chemoattractant were compared with 




CHAPTER 3: S1P ACTIVATES MYOSIN TO PROMOTE BLEB-
BASED, ERM-GUIDED MOTILITY 
3.1:  Results  
ERM proteins are dispensable for S1PR1 expression and endocytosis  
 After identifying that ERM deficiency results in a T cell-intrinsic egress defect and 
a corresponding defect in migration towards S1P, we next sought to determine how 
ERM proteins facilitate S1P responses. Since cell surface expression of S1PR1 and 
ligand-induced endocytosis are both known to impact S1P-dependent T cell egress [38, 
39, 248, 249], we asked if ERM protein expression is required for these events. Across 
multiple secondary lymphoid organs, surface S1PR1 levels on naïve DKO CD4+ T cell 
were normal or slightly elevated (Fig. 3.1a). Surface S1PR1 expression also appeared 
normal in mature DKO thymocyte populations (Fig. 2.5c, e). Additionally, DKO T cells 
displayed low surface expression of S1PR1 when isolated from blood, a high S1P 
environment, indicating that receptor endocytosis in vivo is intact (Fig. 3.1a). To confirm 
that ERM proteins are dispensable for S1PR1 endocytosis, we treated cells with S1P in 
vitro for 30 seconds or 10 minutes, stained for surface S1PR1, and measured loss of 
receptor expression by flow cytometry. WT and DKO T cells showed similar surface 
levels of S1PR1 in culture, and no differences were detected in the efficiency or kinetics 
of endocytosis following S1P treatment (Fig. 3.1b-c).  Thus, we conclude that receptor 
expression and ligand-induced internalization are intact in the absence of ERM proteins. 
ERM proteins are dispensable for S1P-dependent signaling 
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 Since ERM proteins interact with important signaling proteins at the PM [186], we 
asked if DKO T cells show signaling defects downstream of S1PR1 ligation. Studies on 
S1PR1 signaling in lymphocytes are lacking, but S1PR1 has been shown to signal 
through the PI3K/Akt and MAP Kinase pathways in other cell types  [268, 286]. We 
stimulated WT and DKO T cells with S1P for various times and immunoblotted for 
phospho-Akt and phospho-Erk1/2. Both the magnitude and kinetics of signaling were 
similar for WT and DKO T cells (Fig. 3.1d). As a separate readout of S1PR1 signaling, 
we measured actin polymerization, and found no differences in the response of WT and 
DKO T cells (Fig. 3.1e-f). Treatment with the S1PR1 antagonist Ex26 effectively blocked 
actin polymerization, confirming the receptor specificity of this response (data not 
shown). Taken together, these studies show that ERM protein expression is not required 
for ligand-induced S1PR1 internalization or signaling.   
S1P treatment induces rapid dephosphorylation and rephosphorylation of ERM 
proteins 
 Since S1PR1 appeared to be fully signaling-competent in DKO T cells, we 
considered alternative explanations for the transmigration defects observed. ERM 
proteins cycle between an activated conformation at the PM and an auto-inhibited head-
to-tail conformation in the cytoplasm [173]. Activation is mediated by binding of the N-
terminal FERM domain to PIP2 in PM, and by phosphorylation of a critical threonine 
residue in the C-terminal actin binding domain [181]. Chemokine receptor signaling in T 
cells promotes potent ERM dephosphorylation lasting 10-20 minutes, during which time 
the cell can undergo shape changes and molecular reorganization events needed for 
polarized cell motility [184, 217]. We asked if ERM proteins cycle differently in response 
to S1P stimulation. Interestingly, although both CCL19 and S1P induced ERM 
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dephosphorylation at 30 seconds, dephosphorylation was sustained in the CCL19-
treated group, whereas S1P-treated cells showed rapid ERM re-phosphorylation 
between 2- and 5-minutes post stimulation (Fig. 3.2a-b). Thus, the ERM-dependent 
linkage of the actin cortex to the PM is largely intact during S1P but not chemokine 
responses.  
S1P induces a rapid, highly transient mode of motility that depends on ERM 
proteins  
To study the differences between S1P and chemokine induced migration, we 
developed a chemokinesis assay to visualize cell responses following chemoattractant 
stimulation. WT Naïve CD4+ T cells were added to chambers coated with vascular 
adhesion protein-1 (VCAM), and imaged for several minutes at which point S1P, CCL19, 
or CXCL12 was gently dripped into the chamber. Prior to stimulation, VCAM-bound cells 
mostly exhibited a rounded morphology. Addition of S1P induced a rapid burst of 
migration lasting only a few minutes, after which the cells rounded up and stopped 
moving (Supplemental Video 1). In contrast, both CCL19 and CXCL12 induced modest, 
but sustained, chemokinetic responses (Supplemental Videos 2, 3). Quantitative 
analysis of cell velocity confirmed this distinction; S1P induced strong, but short-lived 
responses that returned to baseline within 4-5 minutes whereas CCL19 and CXCL12 
induced sustained migration (Fig. 3.3a). These distinct modes of motility are reflected in 
the kinetics of F-actin polymerization, which is short-lived in S1P-stimulated cells and 
sustained for at least 20 minutes in cells treated with CCL19 (Fig. 3.3b-c). Importantly, 
during the time when S1P treated T cells exhibit maximal motility (approximately 2 
minutes after stimulation, Fig 3.3a), ERM protein phosphorylation has already returned 
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to significant levels (Fig. 3.2). This contrasts with chemokine-stimulated cells, where 
phospho-ERM protein levels remain low during migratory responses (Fig 3.2). 
 We next used this chemokinesis assay to conduct side-by-side analysis of WT 
and DKO T cells. We first quantified the number of cells that migrate in response to each 
chemoattractant, using a threshold of at least 10 microns of displacement. Similar to the 
transwell data (Fig 2.8a), fewer DKO T cells migrated in response to S1P (Fig 3.4a, 
Supplemental Videos 1, 4), whereas the frequency of DKO cells migrating to CCL19 and 
CXCL12 was normal (Fig. 3.4 b). Among the cells that did move at least 10 microns, 
DKO T cells showed reduced displacement and directionality in response to S1P (Fig. 
3.4c, e), but not in response to CCL19 or CXCL12 (Fig. 3.4d, f). These selective defects 
in displacement and directionality are readily observed in plots of cell tracks (Fig. 3.4g-
h).  
S1P induces pressurized, bleb-based migration 
 When quantifying WT and DKO T cell dynamics, we observed that although WT 
cells responding to S1P and chemokines exhibited similar morphologies at early time 
points, their behavior differed dramatically after the first 2-3 minutes. Prior to stimulation, 
cells were rounded and poorly migratory (Fig. 3.5a-b, Pre-treat). Immediately after 
stimulation with either S1P or chemokine (CXCL12 and CCL19 promoted similar 
responses), T cells showed prominent membrane ruffling coincident with a burst of actin 
polymerization (Fig.  3.5a-b, Ruffle, Fig. 3.3b-c). Both sets of cells then polarized and 
began actively migrating. During this initial migratory phase (Fig. 3.5a-b, Lamellipodial), 
both sets of cells exhibited broad, flat lamellipodia at the leading edge (arrowheads), and 
a refractile uropod at the rear. For chemokine-stimulated cells, this morphology was 
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maintained throughout the course of the assay. In contrast, S1P-stimulated cells 
transitioned after 2-3 minutes from a lamellipodial mode of motility to one associated 
with prominent membrane blebbing. Blebbing continued until the end of the migratory 
response, approximately 5 minutes after stimulation (Fig 3.5a, Bleb-based, 
Supplemental Videos 5, 6). Blebs are sites of temporary PM separation from the actin 
cortex [128, 152, 287]. By DIC microscopy, they appear as rapidly-forming balloon-like 
protrusions (Fig. 3.5c). Blebs are highly transient in migrating cells, since actin-rich 
structures fill the space within seconds. Enumeration of these structures revealed that 
S1P stimulation drove a substantial increase in blebbing over unstimulated cells 
(control), whereas chemokine stimulation did not (Fig. 3.5d).  
 Unlike lamellipodia, blebs are pressure-driven protrusions [287]. Intracellular 
pressure is regulated primarily by actomyosin contractility [97]. To determine if S1P was 
driving bleb-based migration through enhanced myosin activity, we treated cells with 
either S1P or CCL19 and immunoblotted for phosphorylation of myosin light chain at 
Thr18/Ser19. Phosphorylation at these sites enhances ATPase activity of the catalytic 
head domain of myosin heavy chain and promotes contractility [115-117]. We also 
probed for AKT phosphorylation as a positive control. S1P and CCL19 both drove 
significant AKT phosphorylation at 0.5 minutes to similar degrees, but this response was 
highly transient for S1P treated relative to CCL19 (Fig. 3.6a, b). As AKT phosphorylation 
diminished, S1P-treated cells showed enhanced MLC phosphorylation peaking at 3.5 
minutes post-stimulation (Fig. 3.6a, c), a time point that corresponds to high levels of 
blebbing in the chemokinesis assay (Fig. 3.5a). CCL19 did not drive any elevation in 




 To determine if this myosin activation resulted in heightened intracellular 
pressure that could be used to drive bleb formation, we utilized the servo-null 
micropressure method, which uses a microelectrode to penetrate the cell membrane and 
directly quantify cytoplasmic pressure, to determine intracellular pressure in T cells 
[288].  Cells were left untreated (none) or stimulated with either S1P or CCL19, and 
intracellular pressure was determined. As shown in Fig. 3.6d, S1P stimulation resulted in 
a significant elevation in intracellular pressure, whereas CCL19 stimulation did not. To 
determine whether this pressure increase was dependent myosin activity, we treated the 
cells with the myosin inhibitor blebbistatin (BBS) prior to S1P stimulation. Treatment with 
BBS alone in resting cells resulted in a significant drop in pressure, consistent with a 
well-described homeostatic role for myosin contractility in regulating pressure [97]. Even 
with their lowered starting values, BBS-treated T cells did not elevate their intracellular 
pressure in response to S1P, indicating that myosin activity is necessary for S1P-
induced pressurization. To determine if myosin inhibition also prevented bleb-formation, 
we repeated the chemokinesis assay in the presence or absence of BBS and quantified 
bleb formation. As shown in Fig 3.6e, S1P induced prominent blebbing, but these 
protrusions were potently inhibited by pre-treatment with BBS. Collectively, these data 
indicate that S1P activates myosin to drive pressurized, bleb-based migration and that 
this migratory response is fundamentally different from the responses elicited by CCL19 
or CXCL12.  
ERM proteins facilitate migration by limiting blebs to the leading edge 
 ERM proteins, which link the PM to the actin cortex, are known to play an 
important role in bleb prevention and resolution [137]. We therefore compared bleb 
formation in WT and DKO T cells during S1P-induced migration. At early times after S1P 
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addition, WT and DKO cells ruffled, polarized, and began to migrate similarly (Fig. 3.7a). 
However, when the transition to blebbing occurred, WT T cells primarily displayed 
blebbing at or near the leading edge, whereas DKO T cells showed indiscriminate 
blebbing all around the cell body (Fig. 3.7a, asterisks, Supplemental Videos 7, 8). To 
quantify this, cells were divided into thirds along the axis of migration (rear, middle, and 
front), and the front third was further divided into “front” and “lead” to distinguish blebs 
that occur strictly at the leading edge. Examples of blebs occurring in each region are 
shown in Figure 3.7b. Videos of WT and DKO T cells were then analyzed for the bleb 
frequency within each region. Blebbing in the rear third of the cell was rarely observed in 
either cell population. In WT T cells, blebbing was progressively more frequent in the 
regions closer to the leading edge (Fig. 3.7c). Relative to WT cells, DKO T cells showed 
elevated blebbing in the middle region and reduced blebbing at the leading edge (Fig. 
3.7c). In WT T cells, bleb area also increased with proximity to the leading edge, with a 
particularly sharp increase between the middle and front/lead regions (Fig. 3.7d). In 
contrast, blebs in DKO T cells were large irrespective of location (Fig. 3.7d). This inability 
to spatially regulate bleb frequency and size likely contributes to the profound 
directionality defects displayed by DKO T cells responding to S1P (Fig. 3.4e).  
 Finally, we asked how the location of ERM proteins within the cell relates to 
directional blebbing. WT T cells bound to VCAM were stimulated with S1P for 1, 2.5, or 5 
minutes, after which they were fixed, labeled for phospho-ERM proteins and 
counterstained for tubulin to identify the centrosome, which is positioned in the rear of 
migratory lymphocytes. Consistent with the western blot data (Fig. 3.2), S1P drove an 
initial dephosphorylation of ERM proteins that recovered after 2.5-5 minutes. At 2.5 
minutes, when cells are highly migratory and beginning to bleb, phosphorylated ERM 
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proteins primarily localized to the rear of the cell; labeling diminished gradually within the 
middle region and was largely absent from the front third of the cell (Fig. 3.7e-f). By five 
minutes post-stimulation, when cells have rounded up and ceased migration, active 
ERM proteins were found all around the cell cortex. Importantly, the regions where ERM 
proteins accumulate in WT cells correspond to regions of low bleb frequency. These are 
the same regions that show elevated blebbing frequency and size in DKO T cells. Taken 
together, these results show that ERM proteins in T cells are largely dispensable for 
lamellipodial migration, but play a critical role in facilitating polarized protrusions during 
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Figure 3.1 ERM proteins are dispensable for S1PR1 expression, endocytosis, and 
signaling. 
(a) Ex vivo surface expression of S1PR1 on WT and DKO naïve CD4+ T cells (gated on Live, 
CD4+, CD62LHi CD44Low) from the spleens, lymph nodes, and blood. Bkgd refers to WT 
CD4+CD8+ thymocytes stained in parallel. Representative flow panels from 3 independent 
experiments shown. (b-c) Ligand-induced S1PR1 endocytosis. WT and DKO naïve CD4+ T cells 
were stimulated with S1P (10 nM) for 0, 0.5, or 10 minutes, stained for surface S1PR1, and 
analyzed by flow cytometry. Bkgd refers to cells stained without primary anti-S1PR1 antibody. 
Pooled data from 4 independent experiments normalized to WT levels prior to stimulation are 
shown as means +/- StdDev and compared at each time point using an t-tests and the 
Holm-Sidak correction for multiple comparisons. (d) S1P-induced signaling. WT and DKO naïve 
CD4+ T cells were stimulated with S1P (1 nM), lysed after 0, 0.5, 2, and 5 minutes, and 
immunoblotted for phospho-Erk (Thr2020/Tyr204), phospho-Akt (Ser473), total ERM proteins, 
and GAPDH. Blot representative of 3 independent experiments. (e-f) S1P-induced actin 
polymerization. WT and DKO naïve CD4+ T cells cultured were stimulated with S1P (1 nM) for 0, 
0.5, 2, or 20 minutes, fixed, stained with phalloidin-AF488, and analyzed by flow cytometry. 
Representative plots and pooled data from four independent experiments shown as means +/- 
StDev and compared at  each time point using multiple t-tests with the Holm-Sidak correction for 
multiple comparisons. No statistically significant differences were observed between WT and 
DKO T cell responses.
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Figure 3.2 S1P-induced ERM inactivation is short-lived relative to chemokine
(a-b) ERM dephosphorylation and rephosphorylation. WT naïve CD4+ T cells were 
stimulated for 0, 0.5, 2, 5, or 15 minutes with S1P (100 nM) or CCL19 (100 ng/mL), lysed, 
and immunoblotted for phospho-ERM (Thr558 for moesin) and total ERM. Quantified 
band intensities displayed as the phospho/total ratio pooled from five independent 
experiments. Means for the S1P and CCL19 group compared at each time point using a 
multiple t-tests and the Holm-Sidak correction for multiple comparisons. *p<0.5
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Figure 3.3 S1P promotes a rapid, highly transient mode of migration
(a) Instantaneous velocity following S1P or chemokine stimulation. WT naïve CD4+ T 
cells were imaged by DIC microscopy before and after stimulation with S1P (100 nM), 
CCL19 (100 ng/mL), or CXCL12 (100 ng/mL), and manually tracked at one-second 
intervals. Instantaneous velocities were smoothed over 5-second windows. Averages + 
StDev for twelve representative cells per condition are shown. (b-c) Actin polymerization 
kinetics following S1P vs Chemokine stimulation. WT naïve CD4+ T cells cultured 
overnight were stimulated with S1P (1 nM) or CCL19 (100 ng/mL), fixed after 0, 0.5, 2, 
or 20 minutes, stained for F-actin, and analyzed by flow cytometry. Representative data 






















































































































































Figure 3.4 ERM proteins are required for S1P-induced chemokinetic responses 
Migration of WT and DKO naïve CD4+ T cells in response to S1P or chemokine. Cells 
were added to VCAM-coated chambers and monitored by DIC microscopy following 
stimulation with S1P (100 nM), CCL19 (100 ng/mL), or CXCL12 (100 ng/mL). (a-b) 
Percentage of cells that displace at least 10 microns during the response. Each dot 
corresponds to a field of cells pooled from three independent experiments shown. Mean 
+/- Std Dev shown and compared individually using t-tests. (c-d) Displacement of WT 
and DKO migratory cells following S1P or chemokine stimulation. Dashed lines show 
10-micron threshold for analysis from (a-b). (e-f) Directionality of migratory WT and DKO 
cells. Directionality was calculated by dividing displacement by total track length. For 
(c-f), pooled data from three independent experiments displayed as individual cells (dots) 
and means (horizontal bars) and compared using Mann-Whitney (non-parametric) 
t-tests. *p<0.5, **p<0.01, ****p<0.0001 (g-h) Tracks of individual cells with the same 
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Figure 3.5 S1P promotes bleb-based migration
(a-b) Representative migratory responses for S1P vs chemokine. WT naïve 
CD4+ T cells were imaged by DIC microscopy on VCAM-coated chambers 
before and after stimulation with S1P (100 nM, (a)), CCL19 (100 ng/mL, not 
shown), or CXCL12 (100 ng/mL, (b)). Scale bars = 5 micron. Time in min:sec 
and relative to point of stimulation. Full arrows = direction of migration, 
arrowheads = lamellipodia, asterisks = blebs. (c) Representative cell showing 
the rapid formation and transient nature of blebs in migratory cells following S1P 
treatment. Time in min:sec and relative to point of stimulation. (d) Bleb 
quantitation following S1P or chemokine stimulation as in (a). Blebs were 
manually counted from DIC movies of control, S1P-, or chemokine-stimulated 
cells on VCAM. Each dot corresponds to a cell pooled from three independent 
experiments. Means (horizontal bars) of S1P, CCL19, and CXCL12 groups 
compared to control using a Kruskal-Wallis One-way ANOVA. 
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Figure 3.6 S1P activates myosin to drive intracellular pressurization and bleb-based migration
(a-c) WT naïve CD4+ T cells were stimulated with S1P (1 nM) or CCL19 (100 ng/mL) for 0, 0.5, 2, 3.5, or 7 
minutes and immunoblotted for phospho-AKT (pAKT; Ser473), total AKT, phospho-myosin light chain 
(ppMLC; Thr18/Ser19), and GAPDH. A representative blot (a) is shown with quantitation pooled from four 
independent experiments (b-c). S1P vs CCL19 AKT phosphorylation (b) was compared using a two-way 
ANOVA with a Sidak correction for multiple comparisons. (c) Activation of myosin was determined using a 
one-sample t test to determine if normalized ppMLC/GAPDH levels were significantly different from a 
hypothetical mean of 1. (d) Intracellular pressure following S1P or chemokine stimulation. WT naïve CD4+ T 
cells were added to PLL-coated plated and left untreated or stimulated with S1P (100 nM) or CCL19 (100 
ng/mL), and pressure was measured by the servo null method between 0-12 minutes of sitmulation. Where 
indicated, blebbistatin (50 micromolar) was added at least 30 mintues prior to stimulation and pressure 
measurement. Each dot corresponds to a cell, pooled from 4 independent experiments. Means (horizontal 
bars) of the S1P and CCL19-treated groups compared to control using a Kruskal-Wallis One-way ANOVA. (e) 
Bleb quantitation following S1P or chemokine stimulation as in fig 3.5. Blebs were manually counted from DIC 
movies of control or S1P-stimulated (100 nM) cells on VCAM. Where indicated, cells were pre-treated with 
s-nitro-blebbistatin (5 micromolar) at least 10 minutes prior to stimulation and imaging. Each dot corresponds 
to a cell pooled from one experiment. Means (horizontal bars) of S1P, CCL19, and CXCL12 groups compared 
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Figure 3.7. ERM proteins facilitate S1P-induced migration by limiting blebs to the leading edge.
(a) Representative S1P-induced bleb-based migration for WT and DKO naïve CD4+ T cells. Cells were 
imaged by DIC microscopy before and after stimulation with S1P (100 nM). Full arrows = direction of 
migration, asterisks = blebs. Time in mm:ss relative to S1P stimulation. Scale bar = 5 microns. (b) An 
illustration depicting a cell divided along the axis of migration and an example of S1P-induced blebs occurring 
in each region (asterisks). Scale bar = 5 microns. (c-d) Bleb frequency and area along the axis of migration. 
Individual cells were tracked during S1P-induced migration, and blebs were binned into the appropriate 
region and area was measured. (c) More than 50 cells pooled from three independent experiments shown as 
the mean +/- SEM compared using multiple t-tests and the Holm-Sidak correction for multiple comparisons. 
(d) Each dot corresponds to an individual bleb (>300 per group), and means compared (red horizontal bars) 
using a Kruskal-Wallis one-way ANOVA. **p<0.01, ****p<0.0001. Dashed line at WT lead mean. (e) Active 
ERM protein localization during S1P migratory responses. WT naïve CD4+ T cells were stimulated with S1P, 
fixed at the indicated time (minutes), stained for phospho-ERM proteins (top) and tubulin (bottom), and 
imaged by confocal fluorescence microscopy. UT = untreated, scale bar = 10 microns. Cells outlined in yellow 
in tubulin channel. Representative images from 3 independent experiments. (f) A representative cell from the 
2.5-minute time point in (e) enlarged and oriented in the same direction as (b). 
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CHAPTER 4: DISCUSSION 
4.1 Summary and Reconciliation with Previous Work  
 The experiments detailed in this dissertation show that S1P promotes a mode of 
cell motility in T cells that is fundamentally different from the response elicited by 
chemokines. Rather than relying solely on actin polymerization-based lamellipodial 
migration, S1P promotes pressurization and blebbing, a mode of migration typically 
reserved for cells tasked with migrating in confinement. During this bleb-based migratory 
response, ERM proteins localize to the rear and sides of polarized T cells where they 
tether the membrane to the underlying actin cortex to limit bleb formation. This process 
restricts blebbing to the leading edge, thereby promoting forward movement of the cell. 
ERM-deficient T cells show dysregulated blebbing, resulting in compromised 
chemokinetic and transmigration responses towards S1P in vitro and defective egress 
from lymphoid tissues in vivo (modelled in Fig. 4.1). 
 The phenotypes of our MKO and DKO mice are essentially identical to those of 
MKO mice independently derived by Hirata et al [224]. They also report lymphocyte 
increases in the spleen, decreases in the lymph nodes, severe decreases in the blood, 
and an accumulation of mature single positive thymocytes in the thymus [224]. While T 
cells in these animals are ezrin-replete, our own data confirms that moesin deficiency 
alone causes perturbations in T cell trafficking, despite the functionally overlapping roles 
typically played by ERM proteins (Fig 2.3). In our hands, many of the trafficking 
phenotypes observed in the MKO mice, including lymphocyte reductions in the blood 
and lymph nodes are worsened by loss of ezrin (Fig 2.3). These data point towards 
functional overlap between ezrin and moesin in T cell trafficking, but with moesin playing 
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a more important role. This is likely due to the higher expression levels of moesin in T 
cells (Fig 2.1). Hirata et al. further pinned down the cell-intrinsic egress defect by using 
integrin-blocking antibodies to stop lymph node entry and show that moesin-deficient T 
cells display significantly lowered egress rates from lymph nodes and the spleen alike. 
With the cell-intrinsic egress defect well-established by our work and that of Hirata et al., 
I focused most of my efforts on understanding the cellular and molecular biology behind 
this egress defect.  
 Hirata et al. report that MKO T cells show defective actin polymerization in 
response to S1P, and a follow-up report by the Hirata group (Nomachi et al. [289]) finds 
that moesin is required for S1PR1 endocytosis. Curiously, Nomachi et al., in direct 
contraction to the previous paper, shows that MKO T cells display enhanced 
transmigration towards S1P. This enhancement is observed without any drug treatment, 
but is made more prominent when WT and MKO T cells are isolated from mice treated 
with FTY720, an S1PR1 functional antagonist that works by driving sustained S1PR1 
internalization and subsequent unresponsiveness to S1P [289]. No attempts were made 
to resolve this contradiction; indeed, the first paper is cited only in regard to the 
generation of the moesin knockout mouse. Like the initial Hirata paper, we show that 
ERM-deficient T cells display diminished S1P transmigration (Fig 2.8). In our hands, 
ERM deficiency had no effect on resting surface S1PR1 levels, consistent with the initial 
Hirata paper (Fig 3.1). Moreover, our quantitative analysis showed no change in the 
magnitude or kinetics of ligand-driven receptor endocytosis or actin polymerization (Fig 
3.1). The basis for these discrepancies is unclear, but one major difference is our use of 
an optimized overnight cell culture protocol, which results in robust responses more 
suitable for quantitative analysis (Fig. 2.7).  
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 Poor in vitro responses to S1P have long plagued the T cell field, and our 
overnight culture approach allowed us to address fundamental questions about S1P-
induced T cell migration. In the sections that follow, I address two major questions that 
emerge from my work. First, how does S1PR1 instruct such a profoundly different 
migratory response than the chemokine receptors tested in this report (4.2)? Second, 
among the various protrusions a T cell can make, are blebs particularly well-suited for 
passage through specialized endothelial layers during egress (4.3)?  
4.2 S1PR1 vs Chemokine Receptor Signaling 
 One of the major findings from my work is that chemokines prompt lamellipodial 
migration in T cells, whereas S1P prompts initial lamellipodial migration followed by 
subsequent myosin-dependent bleb-based migration. S1PR1, CCR7, and CXCR4, the 
receptors tested in my experiments, are all GPCRs, but S1PR1 belongs to the Edg 
family of GPCRs along with other S1P and LPA receptors, whereas CCR7 and CXCR4 
are both members of the chemokine receptor family. Chemokines, by definition, are 
proteins [290], whereas both S1P and LPA are lipids. While S1PR1 is commonly lumped 
in with the chemokine receptors during discussions of T cell trafficking, it is worth noting 
that phylogenetic analysis of Edg and chemokine receptor families reveals these two 
groups are evolutionarily distinct from one another [291, 292]. Despite these genetic 
differences, side-by-side comparisons of cellular responses following Edg vs chemokine 
receptor ligation are rare. All of these GPCRs transmit signals by coupling to 
heterotrimeric G proteins, which are typically classified by their alpha subunits. These 
alpha subunits are organized into four distinct families: Gαs, Gαi, Gαq, and Gα12 [293]. 
S1PR1, CCR7, and CXCR4 all associate with and signal through Gαi under normal 
circumstances [294-299]. As expected, knockout of Gαi or inhibition with pertussis toxin 
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potently interferes with numerous aspects leukocyte trafficking and chemotaxis, 
including S1PR1- and CCR7-dependent processes for T cells in vivo [300-304].  
 While Gαi appears to be crucial for the signaling of all three receptors, it remains 
unclear how the same G alpha protein could mediate the diverse effects observed 
following S1PR1 vs CCR7/CXCR4 ligation. In addition to signaling through G alpha 
proteins, GPCRs can also signal through GRK family proteins, which phosphorylate the 
intracellular tail of activated receptors [305]. Classically, the GRK-mediated 
phosphorylation of active GPCRs and their subsequent arrestin-mediated endocytosis is 
associated with signal termination [306-308]. However, more recent data indicate that 
GRK proteins can influence and sustain GPCR-dependent signaling by serving as a 
protein scaffold [309]. This phenomenon is almost exclusively studied outside the 
context of either leukocytes or cell migration, so there is limited evidence to suggest that 
differential GRK usage between S1PR1 and CCR7/CXCR4 receptors mediates the 
different responses elicited by each receptor detailed in this report. That being said, the 
existing data points towards some interesting differences. First, unlike for Gαi, CCR7 and 
CXCR4 utilize a different GRK protein than S1PR1. CCR7 and CXCR4 are both 
phosphorylated by GRK6 under most circumstances [310-312], whereas S1PR1 utilizes 
GRK2 [248]. GRK6 and GRK2 are in different subfamilies and localize to active GPCRs 
at the PM by completely different mechanisms: GRK6 is palymitoylated and therefore 
membrane-bound, whereas GRK2 is cytoplasmic and binds to βγ subunits that have 
dissociated from Gαi following activation [309, 313-315]. Deletion of GRK6 enhances or 
prolongs chemokine receptor signaling for CCR7 and CXCR4 [311, 312]. A similar 
enhancement has been reported for S1PR1 in T cells deficient in GRK2 for in vitro 
migratory responses, but it is worth noting that GRK2-deficiency results in lymphopenia, 
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which is more suggestive of defective S1PR1 function in vivo [248]. The existing data 
points towards some potentially important differences in GRK protein function 
downstream or S1PR1 vs CCR7/CXCR4, but dedicated studies are required to 
determine what impact, if any, these have on the mode of motility elicited by ligation of 
these different receptors.  
 An important component of dissecting differential GPCR function will be to look 
directly at Rho GTPase activation. GPCRs that modulate cell migration typically exert 
their effects through the activation of the Rho superfamily of small GTPases, which 
include the Rac, Rho, and Cdc42 subfamilies. Classically, Rac activity is necessary for 
lamellipodia formation, Cdc42 for filopodia formation, and Rho for contractility [316-319]. 
For T cells, chemokine receptor signaling typically activates Rac, while S1PR1 signaling 
activates Rho but not Rac [320]. These authors measured Rac activation at 2-minutes 
post-stimulation, so it is presently unclear if S1P does not activate Rac or if the authors 
simply measured too late [320]. Time course studies looking at Rac vs Rho activation 
following S1P and chemokine stimulation are warranted. While we did not specifically 
measure Rac or Rho activation, the literature is consistent with our data showing that 
CCL19 and CXCL12 promote lamellipodia formation and S1P promotes myosin-
dependent blebbing (Fig 3.5). Interestingly, LPA signaling through the receptor Lpar2 
also promotes robust Rho activation in T cells [321], indicating that Rho activation may 
be a common feature of Edg family receptors in T cells.  
 Notably, S1PR1-dependent activation of Rho is not observed in most cell 
systems. In Chinese hamster ovary epithelial cell lines (CHO) [322], primary human 
umbilical vein endothelial cells (HUVECs) [323-325] and megakaryocytes [266], S1PR1 
activates Rac, often without any detectable Rho activation. Yet in some cell lines, 
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S1PR1 drives modifications of cell-cell adhesions through Rho and not Rac [326]. This 
differential activation of Rac and Rho through S1PR1 in various cell types may help to 
explain why S1PR1 ligation results such disparate biological outcomes for different cell 
types, as detailed in the Introduction. One group has attributed these Rac/Rho 
discrepancies to different S1PR1 expression levels among different cell types or 
experimental conditions [327], but I propose here an alternative explanation: endocytosis 
of the receptor. 
 Classically, GPCR endocytosis is associated with signal extinction, but recent 
reports have shown that some GPCRs not only continue to signal following ligand-
induced internalization but engage different signaling cascades from intracellular 
organelles than they do from the plasma membrane [269]. S1PR1 has been shown to 
signal for hours from endosomes in CHO cells when stimulated with the agonist FTY720 
[268]. However, prolonged endosomal signaling in this study is likely secondary to the 
fact that FTY720 cannot be degraded easily by cells through normal S1P lyase-
dependent mechanisms [328]. Still, the natural ligand S1P has been shown to both ligate 
and activate S1PR1 in endosomes in HeLa cells in the context of endosomal maturation 
[273]. Whether endosomal S1PR1 signals in T cells is unknown. Notably, T cells appear 
much more sensitive to ligand-induced S1PR1 endocytosis than endothelial cells [267]. 
Therefore, S1PR1 signaling differences at the PM vs endosomes could begin to explain 
and reconcile the aforementioned Rho GTPase data in T cells vs other cell types as well 
as the different biological outcomes mediated by S1PR1.  
 In further support of this hypothesis are our data showing that S1PR1 doesn’t 
immediately promote blebbing, but instead drives a delayed lamellipodia-to-bleb 
transition. If S1PR1 switched from signaling through Rac at the PM to signaling through 
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Rho in endosomes, it would explain why S1P-stimulated T cells first utilize lamellipodia 
and only transition to myosin-dependent blebbing after 2-3 minutes, when the receptor is 
mostly internalized (Fig 3.1, 3.5, 3.6). This mechanism could also explain why GRK2-
deficient T cells are hyper-responsive to S1P in transwell assays, but potentially 
defective at actual in vivo egress [248]. Sustained Rac activation at the plasma 
membrane may be sufficient for migration through transwell pores, as this would mimic a 
CCR7 response, but if subsequent activation of Rho by internalized S1PR1 was critical 
for actual passage through lymphatic endothelial cells in vivo, it would create an in vitro 
vs in vivo discrepancy like the one observed [248]. Although I was unable to address this 
particular hypothesis during my thesis work, other members of the Burkhardt lab are 
currently doing so by using inhibitors of clathrin-mediated endocytosis to elucidate the 
role of S1PR1 subcellular localization on signaling and T cell migratory responses. 
 In summary, the signaling and cellular responses elicited by S1PR1 in T cells is 
simultaneously distinct from chemokine receptors in T cells and from S1PR1 in 
endothelial cells. Despite using the same G alpha protein, S1PR1 and CCR7/CXCR4 
elicit fundamentally different migratory response in T cells, with S1P uniquely activating 
bleb-based motility. S1PR1 utilizes a different GRK protein and activates different small 
GTPases than the aforementioned chemokine receptors, which likely mediate the 
different migratory responses observed in these experiments. The S1PR1-dependent 
activation of Rho reported by Mou et al. [320] appears to be atypical and may be limited 
to lymphocytes due to significant differences in ligand-induced receptor internalization 
and shuttling between lymphocytes and endothelial cells. While data on the signaling 
cascades needs to be clarified, our data provides a mechanistic explanation for how 
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S1PR1 uniquely promotes blebbing: through myosin activation and intracellular 
pressurization.  
4.3 The role of lamellipodia, blebs, and other protrusions for migration in vivo  
 Perhaps the most obvious question arising from my finding that S1P promotes 
bleb-based migration is why would an egress signal specifically promote blebbing?  Are 
blebs better-suited for breaching the lymphatic sinuses or splenic vasculature where 
egress occurs than actin-based protrusions?  Understanding the role of the specific 
types of protrusions during T cell trafficking is difficult for several reasons. First, live 
intravital imaging experiments, while incredibly informative, often lack the spatial or 
temporal resolution to definitively identify different protrusive structures. The model 
organism best-suited for live cell imaging, the zebrafish, lacks lymph nodes, which 
precludes studies of intranodal migration or typical egress events. Relative to other 
protrusions, blebs are particularly transient and protein-dim, making them hard to 
visualize during intravital imaging experiments in mice. However, careful interpretation of 
in vitro migration studies and in vivo phenotypes can begin to clarify how various 
protrusions facilitate different aspects of T cell trafficking. This section begins with a 
summary of how different protrusive structures – especially lamellipodia and blebs – 
facilitate migration in different contexts in vitro and in vivo and ends with a focus on the 
morphology of egress portals as it relates to bleb-based passage.  
 One particularly crucial distinction between lamellipodial and bleb-based 
migration is that lamellipodial migration requires an adhesive substrate, typically 
provided in the form of immobilized integrin ligands, whereas bleb-based migration 
occurs optimally in minimally adhesive settings, not requiring any specific adhesive 
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contacts [128]. Intravital imaging experiments have shown that T cells migrate directly on 
the network of FRCs in the paracortex [27], which indicates some kind of contact-
dependent guidance, presumably through one or more adhesive interaction. While FRCs 
express the ligands for LFA-1 (ICAM-1) and VLA-4 (VCAM-1), integrins seem to play 
only a minor role in intranodal T cell migration [329]. Woolf et al. found that LFA-1-
deficient T cells show only modest speed and directionality defects relative to WT T 
cells, and that VLA-4 does not provide any compensatory adhesive interactions [329]. 
Similarly, deletion of all integrins from dendritic cells doesn’t detectably impact migration 
to and within lymph nodes [330]. Therefore, while LFA-1 plays a critical role in lymph 
node entry through HEVs, it is not particularly important for intranodal migration. 
 Another candidate for an adhesive ligand that could facilitate lamellipodial 
migration is CCL21. Unlike CCL19, CCL21 remains immobilized on the surface of FRCs 
[331-334]. Surfaces coated with CCL21 alone, in the absence of any integrin ligands, 
promote profound and sustained migration of mouse or human T cells, suggesting that 
CCR7 can function as a weak adhesive receptor in its own right [329]. In this study, 
Immobilized CCL21 drives lamellipodial formation in T cells in the absences of any other 
receptor engagement. Moreover, CCL21 is a potent activator of Rac in T cells and Rac 
is crucial for intranodal migration [320, 329, 335]. Likewise, CCR7 deficiency has a much 
more profound impact on intranodal T cell migration than LFA-1-deficiency does, even 
when HEV entry is bypassed [31]. Although further study is warranted, these data point 
towards a model where immobilized CCL21 promotes Rac activation to drive 
lamellipodial T cell migration on the FRC network in the paracortex. Utilizing 
lamellipodial migration in the paracortex likely has an added benefit, as T cell receptors 
within lamellipodia are particularly sensitive to stimulation [336, 337]. Thus, a single 
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protrusive structure could facilitate both migration and the scanning of APCs that have 
collected in the paracortex for rare, cognate antigen [338].   
 While intravital imaging studies have shown that T cells are almost always 
associated with the stromal network in the paracortex, T cells do occasionally appear 
either weakly associated or fully detached from any FRC [27]. In vitro studies have 
shown that T cells can migrate in collagen matrices in the absence of any specific 
integrin ligands or immobilized chemokines, a process that is especially important in 
non-lymphoid organs where specialized FRC networks are not present [339, 340]. Work 
by Lämmerman et al. found that dendritic cell migration through collagen gels was 
independent of integrins or any specific adhesive interactions, instead relying heavily on 
Cdc42 activity and actomyosin contractions [330, 341]. Notably, Cdc42 is much more 
critical for three-dimensional collagen matrix migration than two-dimensional adhesion-
dependent migration [341]. The authors were unable to study Cdc42-deficiency during 
intranodal migration because the defect in these cells in getting to the lymph node was 
too profound  [341]. In three-dimensional environments, the leading edges of leukocytes 
are often broad and actin-rich, but lacking the telltale characteristics of both lamellipodia 
or filipodia and therefore are more aptly referred to simply as pseudopods or leading 
edges. The role of Cdc42 in T cell migration has been difficult to study due to the fact 
that this GTPase is absolutely critical for T cell development [342, 343], but these data 
collectively point towards Cdc42 being especially important in leukocytes for adhesion-
independent, actin-based migration in three-dimensional environments. 
 Rho-depleted T cells either fail to polarize or they show defects in trailing edge 
retraction that results in inefficient transendothelial migration in vitro [344]. To my 
knowledge, intravital imaging studies have not been performed for Rho-deficient T cells, 
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but T cells deficient in myosin, the major Rho effector protein, display defective motility 
within the lymph nodes [345]. However, these defects in intranodal migration are mild 
compared to Rac-deficiency: Rac-deficient T display a roughly 70% decrease in median 
instantaneous velocity compared to a 30% decrease for myosin-deficient T cells [335, 
345]. In addition to their mild intranodal migration defects, myosin-deficient T cells 
display decreased entry into lymph nodes, often remaining bound to HEVs apparently 
unable to transverse. These cells are also retained in lymph nodes for abnormally long 
periods of time, suggestive of an egress defect, although egress has not been directly 
tested [345]. Mou et al [320] showed previously that S1P selectively activates Rho in T 
cells, and we now demonstrate S1P activates myosin to promote bleb-base migration 
(Fig 3.6). Consistent with a barrier-crossing role for myosin, in vitro studies have shown 
that myosin becomes increasingly important for T cell transwell migration as the pores 
become increasingly narrow and restrictive [346]. Taken together, these data support a 
model in which S1P signaling through S1PR1 activates Rho to promote myosin-
dependent bleb-based migration, which in turn promotes passage through confined 
spaces, and egress from lymphoid organs. 
 To summarize, the functions of Rac, Cdc42, Rho, and their associated 
protrusions in leukocyte migration are diverse, and their depletion or inhibition often 
results in complex phenotypes. However, the extant data on leukocytes point towards 
Rac being particularly critical for adhesion-mediated migration on FRC networks, Cdc42 
being particularly critical for adhesion-independent migration in extracellular matrices, 
and Rho being particularly critical for myosin-dependent rear retraction and barrier 
crossing events. In this context, we propose that S1P induces lymphatic sinus and 
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splenic endothelial crossing events by promoting myosin-dependent blebbing rather than 
relying solely on actin-based protrusions. 
Egress portals are unique barriers 
 This leads to most important topic in this discussion, which is the question of why 
blebs useful for egress. To begin to answer this question, I will first discuss in vitro data 
and modeling that compares the effectiveness of actin-based and bleb-based motility in 
varying contexts. This will then be followed by a discussion of the morphology of the 
endothelial barriers that stand between T cells and the circulatory fluids, where blebs are 
implicated for passage.  
 One particularly salient study (Tozluoğlu et al. [347]) modeled the migration of 
metastatic cancer cells, which show extreme plasticity in their protrusion type, in three 
separate environments: two-dimensional surfaces, continuous confinement, and 
discontinuous confinement. Continuous confinement is similar to migration in a 
microchannel, and discontinuous confinement is more akin to a dense collagen gel with 
various pore sizes that must be traversed. In line with previous experimental data, these 
models predict blebs to be minimally effective in two-dimensions, where actin-based 
protrusions are preferred [347, 348]. Both actin-based and bleb-based migration are 
effective in continuous confinement, but somewhat surprisingly, blebs are significantly 
more effective than actin-based protrusions in discontinuous confinement, especially 
when adhesive ligands are scant or entirely absent [347]. These models predict that the 
pressure-driven nature of blebs allows them to easily find pre-existing discontinuities in 
the complex matrix, allowing the cell to identify paths of least resistance.  
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 How do paths of least resistance relate to cells traversing an endothelial layer 
during egress? Most endothelial layers form tight, continuous “zipper-like” cell-to-cell 
junctions that do not resemble the discontinuous confinement modeled by Tozluoğlu et 
al. [347], and T cells conspicuously do not use S1PR1 or blebs to cross at these sites, 
instead relying on chemokine receptors and actin-rich podosomes [349, 350]. However, 
Baluk et al. [351] report that blunt-end lymphatic sinus endothelial cells, where S1PR1-
dependent egress occurs, form overlapping flaps with discontinuous adhesion 
molecules, resulting in “button-like” barriers [351]. These button-like barriers permit 
perpetual passage of fluid into lymphatics, which is important for antigen delivery to 
lymph nodes and the prevention of edema. Leukocytes enter these sinuses by 
squeezing through pre-existing discontinuities in the sinus barrier [352]. These “button-
like” vessels were initially described from imaging studies of lymphatics that drain 
peripheral non-lymphoid tissues, and were observed at entry sites but not deeper into 
the vessels, where lymph needs to be efficiently transported [351]. The morphology of 
lymphatic sinuses in lymph nodes is less well-characterized, due in part to the extreme 
heterogeneity of lymphatic endothelial cells in these sites [353]. Our understanding of 
the morphology of sinuses in the lymph node cortex comes almost entirely from electron 
microscopy characterization of lymph nodes from various species conducted from the 
1960s to 1980s. While some reports concluded that LEC layers in lymph nodes are 
continuous [354], others report the presence of pre-existing discontinues on the scale 
reported by Baluk et al. [351] for peripheral lymphatics, some of which are filled with 
transmigrating leukocytes [353, 355-358]. T cell tracking in lymph nodes has shown that 
T cells tend to enter lymphatic sinuses through common portal sites, which is consistent 
with the presence of preformed discontinuities [36, 359]. 
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  More research dedicated to the morphology of LEC barriers in lymph nodes is 
warranted, but the existing data point towards discontinuous barriers being common at 
the regions where S1PR1-dependent egress occurs and where blebs are implicated. For 
T cells interacting with these lymphatic sinuses and sensing S1P, blebs may 
preferentially expand into these spaces between the “buttons” to pass from the lymph 
node parenchyma into the sinus. While the spatial and temporal resolution from the 
available intravital imaging studies is not high enough to confidently determine protrusive 
structures, T cells transmigrating in vivo appear to squeeze through adjacent LECs with 
large, rounded leading edges, potentially indicative of a bleb-based mechanism [36, 
359]. This consistent with electron micrographs showing invasive adenocarcinoma cells 
accessing peripheral lymphatics by extending rounded cytoplasmic projections, likely 
blebs, between adjacent LECs [360].  
 Almost everything that is known about tissue architecture at egress sites comes 
from analysis of lymph nodes, however S1P is also important for egress from the thymus 
and spleen, which occurs either primarily or exclusively into blood rather than lymph [39, 
235, 361]. It is unclear if these vascular entry points resemble typical zipper-like blood 
endothelium or button-like lymphatic sinuses. Egress from the spleen has never been 
visualized despite extensive efforts, and the egress sites are unknown [46]. Vascular 
egress sites in the thymus, however, have been relatively well-characterized. Egress 
from the thymus occurs through blood vessels at the corticomedullary junction [361, 
362]. These vessels are surrounded by a prominent perivascular space (PVS), which is 
further separated from the thymic epithelial space (TES) where thymopoiesis occurs by 
a prominent basement membrane and epithelial sheath [361, 363, 364]. PVSs are 
common in the brain, but uncommon in peripheral tissues where podosome-dependent 
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processes are thought to mediate T cell barrier crossing [365]. This PVS is often 
occupied with mature single positive thymocytes in the process of egressing, and forcing 
premature expression of S1PR1 causes a prominent accumulation of immature 
thymocytes in the perivascular space followed by their eventual release into circulation 
[361, 366]. It is unclear if S1PR1 only facilitates movement from the TES into the PVS or 
if it is also necessary subsequent passage into the venule. Notably, early electron 
microscopy studies of the rodent thymus demonstrated that thymocytes appear to 
breach this epithelial sheath surrounding the PVS through pre-existing discontinuities in 
the barrier [367, 368], suggesting this S1PR1-dependent step may occur in a similar 
fashion as lymphatic egress.  
 The emerging picture from these data is that the specialized entry and egress 
sites that facilitate homeostatic T cell trafficking are structurally different from “textbook” 
peripheral blood endothelial layers, and that these atypical structures may be particularly 
permissive to bleb-based passage. While chemokines are critical for passage across 
blood endothelial layers in vitro and in vivo [369], S1P is selectively critical for passage 
across lymphatic endothelium in vitro and in vivo [256]. This relationship between 
endothelial morphology and the permissiveness to different protrusions warrants further 
study, especially considering the central role that transendothelial migration plays in 
inflammatory diseases and the metastatic spread of cancers.  
Concluding Remarks  
 Sphingosine is named after the Sphinx, a human/bird/lion hybrid in Greek 
mythology that devours travelers if they cannot answer her riddle: What goes on four 
feet in the morning, two feet at noon, and three feet in the evening? It was named after 
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the sphinx as a nod to the enigmatic, frustrating nature of the lipid [233, 370]. The fact 
that this riddle pertains to movement is purely coincidental. I can personally attest that 
S1P does justice to the family name, but I believe the data outlined in this thesis have 
begun to clarify the unique role for this lipid in T cell trafficking.  
 The role of blebs in T cell trafficking will be most directly solved by in vivo 
imaging, but current technology is unlikely to be able to detect blebs in lymph nodes. 
There are some compromises that can be made, however. If S1PR1-mediated egress 
from peripheral tissues also promotes bleb-based motility, substantially higher temporal 
and spatial resolution can be observed in ear explant imaging experiments, as routinely 
performed by Michael Sixt’s lab (Compare, for instance, supplementary movie 3 in 
Grigorova et al. 2008 [36] to videos 4-6 in Pflicke et al. 2009 [352]). Zebrafish have 
lymphatic networks extremely similar to those present in mammals [371, 372], and may 
therefore be useful for determining the role of blebs in leukocyte trafficking. Zebrafish are 
the primary model organism where bleb-based motility has been unambiguously 
observed in vivo, although these observations are limited to primordial germ cell 
migration [135, 150, 373, 374].  
 Migration throughout the host is an incredibly complex process, and there are 
undoubtedly still many Sphinxes with many riddles. I hope the contributions detailed in 
this report add to our collective understanding of leukocyte trafficking and provide a 

























Figure 4.1 A model for the role of ERM proteins in lamellipodial and 
bleb-based migration 
Illustrations showing cell morphology and protrusive structures in WT and 
ERM-deficient T cells migrating using lamellipodia (left) and blebs (right). 
Lamellipodial migration appears largely unaffected by the absence of ERM 
proteins. Wild type cells migrating by blebs primarily show protrusions at the 
front or leading edge of the cell. When a bleb forms outside the front region of 
the cell, it is typically small. This polarized blebbing is facilitated by the rearward 
localization of ERM proteins. In the absence of ERM proteins, blebs form 





Materials and Methods 
Mice. Moesin knockout mice were generated by and purchased from the Texas A&M 
Institute for Genomic Medicine. A gene trap vector was inserted into the first intron of the 
Msn gene on the X chromosome in 129/Sv ES clones (OST432827), and live mice with 
germline insertion were generated on the 129Sv x C57BL/6 background. The resulting 
moesin knockout (MKO) mice were backcrossed for ten generations to mice of the 
C57BL/6 background (Jackson Laboratories). Mice homozygous for a floxed ezrin gene 
and transgenic for CD4-Cre (EKO, previously described in Shaffer et al. 2009 [217]) on 
the C57BL/6 background were then crossed to the MKO mice, to generate mice bearing 
germline deletion of moesin and deletion of ezrin late in T cell development (female: 
Msn-/-Ezrinflox/floxCD4-Cre+ or male: Msn-/YEzrinflox/floxCD4-Cre+). Loss of moesin and ezrin 
expression in mature T cells was confirmed by RT-PCR and western blotting. For most 
experiments, sex-matched WT littermates were used as controls. Age and sex matched 
controls were used when littermates were not available or possible. All mice were 
housed under barrier conditions in the Children’s Hospital of Philadelphia animal facility, 
in accordance with protocols approved by the Institutional Animal Care and Use 
Committee. 
Flow Cytometry. Spleens, lymph nodes, and thymi were harvested from 8-16-week-old 
mice, and single cell suspensions were prepared. PBMCs were isolated with 
Lymphoprep (STEMCELL). Cells were counted and stained with fluorochrome-
conjugated antibodies towards CD3, CD4, CD8, CD44, CD62L, B220, and NK1.1 
(Biolegend, BD Biosciences, Tonbo) and live-dead aqua or blue (Thermo Fisher 
Scientific). For S1PR1, staining was done in lipid-free FACS buffer (PBS + 1% CS-FBS 
+ 1 mM EDTA). Cells were stained sequentially with rat anti-S1PR1 (R&D MAB7089), 
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donkey anti rat IgG-biotin F(ab’)2 (Jackson Immunoresearch 712-066-153), and 
Streptavidin-APC (Biolegend 405207). For S1PR1 endocytosis experiments, cells were 
stimulated with S1P (10 nM) for the indicated times, and endocytosis was stopped by 
adding ice-cold PBS and washing twice with lipid-free FACS buffer prior to surface 
staining. For F-actin measurements, cells were stimulated with S1P (1 nM) or CCL19 
(100 ng/mL) and fixed with 3% paraformaldehyde at the indicated times. Cells were then 
permeabilized with PSG (PBS + 0.01% saponin + 0.25% fish skin gelatin) and labeled 
with phalloidin Alexa Fluor 488 (Invitrogen) and anti-CD4-APC (RM4-5, BioLegend). All 
samples were analyzed on either an LSR Fortessa or LSRII (BD biosciences) equipped 
with FACSDiva software (BD Biosciences). Data was analyzed using FlowJo software 
(v.10.4.2). 
Immunofluorescence on tissue sections. Spleens and lymph nodes were fixed for 2-4 
hours in 4% PFA in PBS, washed, and incubated overnight in 30% sucrose in PBS. 
Tissues were embedded in OCT and sectioned using a crytostat. Sections were blocked 
for 30 minutes in staining solution (5% donkey serum in PBS-Tween) containing 
FcRblock and subsequently incubated overnight at 4°C in staining solution with 1-2 
ng/µL of fluorescently-labelled anti-mouse antibodies against CD3-AF647 (Clone 17A2, 
Biolegend), B220-BV421 (Clone RA3-6B2, Biolegend) and Laminin 1+2 (rabbit anti-
mouse, AB7463, Abcam, labelled with CF568 Mix-n-stainTM antibody labelling kit from 
Biotium). After washing in PBS, slides were mounted using ProLongTM Diamond antifade 
(Invitrogen), and imaged at 10-20X using a Zeiss LSM710 confocal microscope. Images 
were processes and analyzed using Zeiss Blue 3.1 (Zeiss) and Volocity 6.3. (Perkin 
Elmer) software.  
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Competitive In Vivo Migration. Naïve CD4+ T cells isolated from the spleens and 
lymph nodes of age and sex matched DKO (CD45.2+) and congenic WT CD45.1+ 
B6.SJL-Ptprca mice (Jackson) were labelled with 1 uM CellTracker Green CMFDA 
(Thermo), washed, and mixed at a 1:1 ratio in PBS. 1x106 total cells were injected into 
the tail veins of recipient animals. Recipients were euthanized at 1 or 24 hours after 
injection. Cells from blood, spleens, and lymph nodes were harvested, stained for CD4, 
CD45.1, CD45.2 and with a L/D stain (Biolegend, Tonbo), and analyzed by flow 
cytometry. Input cells were analyzed in parallel. CellTracker Green was used to 
distinguish between donor and recipient cells, and WT and DKO were further 
distinguished by CD45.1/CD45.2 expression. Final ratios were normalized to the 
corresponding input ratios.  
T cell purification and culture. For functional studies, lymphoid organs were harvested 
into ice cold PBS, 0.5% fatty acid free BSA, 1mM EDTA (MACS Buffer) and cell 
suspensions were prepared.  Naïve CD4+ T cells were harvested by negative magnetic 
selection (Miltenyi), washed extensively in MACS buffer, and resuspended in DMEM 
with 10% charcoal-stripped FBS (Gibco). Cells were cultured overnight at 37°C and 5% 
CO2 prior to use.  
S1P preparation. Sphingosine-1-Phosphate d18:1 (Avanti) powder was solubilized in 
methanol:water 95:5 at 50°C with sonication. The solvent was evaporated using dry 
nitrogen to create a film of S1P on the interior of the vessel, which was resuspended in 
Milli-Q water supplemented with 4 mg/mL of fatty acid free BSA (Roche) to a final 
concentration of 100 µM. The S1P-BSA solution was stored at -20°C in tightly-sealed 
glass vials and diluted into cell culture media immediately prior to use.  
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Transmigration Assays. 1x105 T cells in DMEM supplemented with 10% CS-FBS were 
added into a 5-micron transwell insert (Corning) in an empty well to allow them settle for 
20 minutes. The insert was gently lowered into a well containing the indicated 
chemoattractant. In some experiments, the 20-minute settling phase doubled as a pre-
incubation with 100 nM of Ex26 (Tocris). An identical concentration of the drug was 
included in the lower chamber. After 90 minutes, transwell inserts were gently removed, 
and the number of cells in the lower chamber were enumerated on a hemocytometer.  
Microscopy. Eight well chambers (Lab-Tek #1.0 Borosilicate) were coated with 2 ug/mL 
recombinant mouse VCAM-1 (R&D) overnight at 4°C and washed before use. For live 
cell imaging, cells in Phenol Red-free L-15 medium (Gibco) + glucose (2 mg/mL) were 
allowed to settle in the chambers for 30 minutes and then imaged by DIC microscopy at 
37°C using either a 40x or 63x objective on a Zeiss Axiovert 200M inverted microscope 
equipped with an MS-2000 automatic stage (Applied Scientific Instruments) and a Roper 
Scientific electron-multiplying CCD camera. For experiments that include blebbistatin (5 
µM s-nitro-blebbistatin, Cayman), this settling phase doubled as a pre-incubation period. 
Time-lapse imaging was performed using Slidebook 6 software (Intelligent Imaging 
Innovations Inc.). Cells were imaged for several minutes at which point S1P, CCL19, or 
CXCL12 was dripped into the chamber, and acquisition was continued for 10 minutes. 
Images were collected at 1-second intervals. For studies involving immunofluorescence 
microscopy of fixed cells, cells were allowed to adhere to VCAM-coated surfaces and 
stimulated with S1P. At the indicated time after addition of S1P, the media was gently 
removed and the cells were fixed for 20 minutes in a solution of 10% w/v trichloroacetic 
acid to preserve ERM phosphorylation [375], Cells were then permeabilized with 0.1% 
Triton X-100 in PBS, blocked with PBS, 0.01% saponin, and 0.25% gelatin, stained with 
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rabbit with anti-phospho ERM (CST#3141) and rat anti-tubulin (clone YL1/2) for 1 hour in 
PSG, washed three times, stained with anti-rabbit AlexaFluor647 and anti-rat 
AlexaFluor488 (Invitrogen), washed, and imaged using a 63x PLAN Apo 1.4 NA 
objective on an Axiovert 200M (Zeiss) with a spinning disc confocal system (UltraVIEW 
ERS6, Perkin Elmer) equipped with an ORCA-ER camera (Hammatsu). Image 
processing was performed both using Volocity v6.3 software (Perkin Elmer) and ImageJ 
(NIH). All images were prepared for publication in ImageJ. 
Cell tracking. DIC chemokinesis assay movies were exported into ImageJ and cells 
were tracked using the Manual Tracking plugin. For analyzing velocity (Fig. 5c), twelve 
representative cells were tracked at the one-second acquisition rate, and the 
instantaneous velocity was smoothed over five-second intervals before displaying. For 
ease, most videos were reduced to every fifth frame prior to tracking. The different 
response kinetics with S1P and chemokines forced us to analyze and track cells in each 
stimulation condition differently. Following stimulation, S1P-treated cells were tracked 
until the cell characteristically stopped migrating and rounded up, which generally 
occurred 4-5 minutes post-stimulation (Fig.  5c). Given the slower but more sustained 
chemokine response, chemokine-treated cells were tracked for 7 minutes. Due to these 
differences in analysis, the different treatment conditions are graphed separately. Cells 
that left the field of view, landed after stimulation, or dislodged while tracking were not 
included. Dislodgement was a minor issue for S1P-treated cells, and generally only 
occurred after the cell had rounded up. Dislodgement was a serious issue with CCL19 
and CXCL12 treatment, affecting roughly half of the otherwise analyzable cells. We 
considered this a tolerable problem since it allowed S1P and chemokine treatment to be 
compared under the same experimental conditions.   
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Bleb quantitation. In order for a protrusion to be classified as a bleb by DIC 
microscopy, three criteria had to be met. First, the protrusion had to form rapidly, 
generally in less than one second. Second, the edge of the bleb has to appear smooth 
and symmetrical, which contrasts with the roughness and irregularity of actin-rich 
protrusions and edges. Third, the contents of the protrusion had to be clear and devoid 
of any obvious granules or organelles. These metrics were modified from Zatulovskiy et 
al [152]. Once a bleb was identified, it was outlined in ImageJ and the area was 
calculated. Based on the direction of migration, the bleb was then determined to have 
occurred in either the rear, middle, front, or lead regions of the cell.  
Immunoblotting. For experiments involving stimulation, 200 uL of cells in DMEM were 
added to an Eppendorf and stimulated with 50 uL of 5x S1P (1 nM final). To stop, 1 mL 
of ice-cold PBS was added, cells were rapidly centrifuged, and resuspended in lysis 
buffer (50 mM Tris-HCl, 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 30 mM Na4P2O7, 50 
mM b-glycerophosphate, and 1% Triton X-100 in water). Cells were lysed on ice for 30 
minutes with occasional vortexing then microfuged for 10 minutes. Lysates were moved 
to tubes containing NuPAGE LDS sample buffer (Thermo) and boiled for 5 minutes. 
Samples were then resolved on Bis-Tris 4-12% gradient gels (NuPAGE), transferred to 
nitrocellulose membranes, washed with TBST, and immunoblotted overnight at 4°C in 
2% BSA (w/v) TBST. The following antibodies were used for immunoblotting in this 
report: Anti-ERM (Cell Signaling Technology #3142), anti-moesin (BD Biosciences clone 
38, recognizes all family members), anti-phospho ERM (Cell Signaling #3141), anti-
GAPDH (Millipore Sigma MAB374), anti-phospho Erk1/2 Thr202/Try204 (Cell Signaling 
#9101), anti-phospho Akt Ser473 (Cell Signaling #4060). Following overnight incubation, 
membranes were washed multiple times with TBST and then stained with anti-rabbit or 
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anti-mouse secondary antibodies conjugated to AlexaFluor680 (Thermo) or IRDye 
800CW (Licor). Immunoblots were read on a Licor Odyssey imaging system and 
quantified using ImageStudioLite (v. 5.2.5).  
Measuring intracellular pressure (Pic). The intracellular pressure of T cells was 
directly measured using the micropressure measurement technique [288]. We used a 
900A micropressure system (World Precision Instruments) connected to a 0.5 μM 
micropipette that is filled with a 1 M KCl solution and calibrated in a chamber with 0.1 M 
KCl solution to set the overall electrical resistance of the system to zero or null. When 
measuring the intracellular pressure, the tip of the micropipette is inserted through the 
plasma membrane. A positive intracellular pressure pushes the electrolyte solution 
further up the micropipette. The micropressure machine compensates by increasing the 
pressure of an air column until a null setting is restored. This pressure value is 
equivalent to the intracellular pressure. An MPC-325 micromanipulator (Sutter 
Instrument) installed on an LSM700 laser scanning confocal microscope (Zeiss) was 
used to position micropipette within the chamber (37°C and 10% CO2). For these 
experiments, T cells were plated in chambers coated with Poly-L Lysine (Sigma) in 
DMEM. Cells were left untreated (control), or stimulated with either S1P or CCL19. For 
experiments using blebbistatin (50 µM), cells were pre-treated for 30-60 minutes prior to 
stimulation. T cell pressure measurements were taken for 2-3 seconds and the average 
pressure reading during this interval was taken as the cytoplasmic hydraulic pressure of 
the cell. 
Statistical analysis. All statistical tests were performed and graphs were made using 
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